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Early diagnosis and identification of precancer in the colon remains a great 
challenge in conventional white-light endoscopic examination. In recent years, 
optical methods such as autofluorescence (AF) technique, which are capable of 
detecting the changes of endogenous fluorophores and morphological architectures, 
have shown promising diagnostic potential for in vivo detection of precancer at 
endoscopy. Moreover, the near-infrared (NIR) light (700-1000 nm) is non-
carcinogenic, and it is safe for tissue diagnosis. Both the excitation light used and 
the resulting tissue AF are at NIR wavelengths that can penetrate deeper into the 
tissue. Thus NIR AF could potentially be useful for the noninvasive in vivo detection 
of lesions located deeper inside the tissue. This dissertation presents the 
investigation on the diagnostic utility of NIR AF imaging and spectroscopy to detect 
precancer and cancer in the colon. 
We have developed a novel integrated NIR AF and NIR diffuse reflectance 
(DR) imaging technique for colon cancer detection. 48 paired colonic tissue 
specimens (normal vs. cancer) were tested to evaluate the diagnostic feasibility of 
NIR AF imaging for differentiating cancer from normal tissues. The results suggest 
that the colon cancer tissues can be well separated from normal colonic tissues. The 
polarization technique was also coupled into the integrated NIR AF imaging system 
to further improve the diagnostic accuracy for colon cancer demarcation. The ratio 
imaging of NIR DR to NIR AF with polarization conditions achieved the best 
diagnostic accuracy of 95.8% among the NIR AF and NIR DR imaging modalities, 
affirming the potential of the integrated NIR AF/DR imaging with polarization for 
improving the early detection and diagnosis of malignant lesions in the colon. 
We have also developed an endoscope-based NIR AF spectroscopy technique 
to realize real-time in vivo NIR AF spectra measurements from colonic tissue during 
clinical colonoscopic examination. Under the guidance of conventional wide-field 
endoscopic imaging, a novel bifurcated flexible fiber-probe, which can pass down 
the instrument channel of medical endoscopes, has been developed and integrated 
into the NIR AF spectroscopy system to measure in vivo NIR AF spectra from 
different types of colonic tissues from 100 patients, including normal (n=116), 
hyperplastic polyp (benign abnormalities) (n=48), and adenomatous polyps 
(precancer) (n=34). Multivariate statistical techniques (principal components 
analysis (PCA) combined with linear discriminate analysis (LDA)) are employed for 
developing effective diagnostic algorithms for classification of different colonic 
 V
tissue types. The diagnostic algorithms yield overall accuracies of 88.9%, 85.4% and 
91.4% respectively, for classification of colonic normal, hyperplastic, and 
adenomatous polyps. This indicates that NIR AF spectroscopy is a unique diagnostic 
means for in vivo diagnosis and characterization of precancerous and cancerous 
colonic tissues.  
To further investigate the origins of tissue biochemicals responsible for the 
differences of NIR AF among different types of colonic tissues, we have constructed 
a non-negativity-constrained least squares minimization (NNCLSM) biochemical 
model to estimate the biochemical compositions of colonic tissues. The NIR AF 
spectra from the nine representative biochemicals (i.e., collagen I, elastin, β-NADH, 
FAD, L-tryptophan, hematoporphyrin, 4-pyridoxic acid, pyridoxal 5’-phosphate, and 
water) were found the most significant in colonic tissue for optimally fitting the 
measured in vivo NIR AF spectra colonic tissue. Colonic precancer and cancer 
tissues show lower fit coefficients belonging to collagen I, FAD, β-NADH, L-
tryptophan, and pyridoxal 5’-phosphate, and higher fit coefficients belonging to 
hematoporphyrin, 4-pyridoxic acid, and water as compared to benign tissues. We 
also compared the fitting results between in vivo and ex vivo datasets. NIR AF 
spectroscopy provides new insights into biochemical changes of colonic tissue 
associated with cell proliferation and metabolic rate during the cancer progression.   
Moreover, we have also investigated the diagnostic ability of the integrated 
visible (VIS) and NIR DR spectroscopy technique for detection and diagnosis of 
colon cancer. High-quality integrated VIS-NIR DR spectra (400-1000 nm) from 
normal and cancer colonic mucosal tissue were acquired within 8 msec and 
significant differences are observed in DR spectra between normal (n=58) and 
cancer (n=48) colonic tissue, particularly in the spectral bands near 420, 540, 580 
and 1000 nm, which are primarily correlated to absorption of hemoglobin and water. 
Best differentiation between normal and cancer tissues can be achieved using the 
integrated VIS-NIR DR spectroscopy as compared to VIS or NIR DR spectroscopy 
alone, indicating the potential of the integrated VIS-NIR DR together with PCA-
LDA algorithms for improving early diagnosis of colon cancer. 
The results of this dissertation establishe a proof of principle that NIR 
AF/DR imaging and spectroscopy techniques have the potential to be a clinically 
useful tool to complement the conventional white light endoscopy for non-invasive 
in vivo diagnosis and detection of colonic precancer and cancer during clinical 
colonoscopic screening. 
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Chapter 1 Introduction 
1.1  Overview of Colon Cancer 
Cancer that develops in the colon and rectum is called colon cancer or colorectal 
cancer. Colon cancer is a common type of malignancy, which has uncontrolled 
growth of the cells that line inside the colon or rectum. The colon is primarily 
responsible for the absorption of water and mineral nutrients from solid wastes 
before they are eliminated from the body. Fig. 1.1 shows the anatomy of the colon 
that is a muscular tube and has 4 sections: ascending colon (the vertical segment 
located on the right side of the abdomen), transverse colon (extending across the 
abdomen), descending colon (leading vertically down the left side of the abdomen) 
and sigmoid colon (extending to the rectum) [1].  
 
Fig. 1.1 Anatomy of the colon [2]. 
 
Colon cancer arises from a series of genomic alterations that result in 
transformation of a normal epithelial cell into an adenocarcinoma cell. The biology 
of colon cancer is complex and involves concepts such as genomic alterations, 
Transverse 












multistage carcinogenesis, oncogene activation, expansion of clones of neoplastic 
cell, homeostatic control of cell growth, and cell invasion [3]. The development of 
colon cancer is characterized by a progressively disordered genome and perturbed 
biology [4]. Fig. 1.2 shows the proliferation and growth of cancer cells invading 
through the basement membrane. The traditional understanding of developing colon 
cancer is based on the concept of the adenoma-carcinoma sequence [5-6]. According 
to this theory, benign precancerous colon lesions (e.g. adenomatous polyps) 
gradually transform to invasive cancer over time, and thus, early detection and 
removal of these precancerous polyps has been widely accepted to effectively 
prevent colon cancer development and decrease the associated mortality rate [7].  
 
Fig. 1.2 Conceptualization of morphologic progression through oncogenesis, 
incorporating altered cell relationships, and invasion through the basement 
membrane [8]. 
 
Colon cancer has become the third leading cause of cancer-related death, 
accounting for approximately 655,000 annual deaths worldwide [9]. The incidence 
of colon cancer varies with the economic development of individual countries, 
including the level of affluence and westernization of lifestyle [10]. For example, the 
highest incidence rates are found in Australia and North America, whereas the 
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lowest rates are found in Africa and South-central Asia [11]. In Singapore, the 
incidence of colon cancer has increased dramatically over the past three decades; 
colon cancer has become the most common malignancy for males and the second 
most common for females [12]. A number of factors appear to increase an 
individual’s risk for colon cancer, including older age, male gender, diet and exercise 
habits, a history of inflammatory bowel disease, certain genetic syndromes, and a 
family history of colon cancer or adenomatous polyps [13].  
Currently, both the incidence and mortality rates for colon cancer have been 
stable and even declining in some developed countries [9, 11]. The declining 
mortality and incidence rates might reflect the improving preventive methods for the 
early detection and treatment of adenomatous polyps and non-invasive cancers 
before they advance to metastatic carcinomas. According to the America Joint 
Committee on Cancer (AJCC) staging of colon cancer [14], if the colon cancer is 
diagnosed while it is still localized or confined to the primary site (stage I/IIa), the 
survival rate is 90% at 5 years; if the cancer has spread to regional lymph nodes 
(stage III) or directly beyond the primary site (stage IIIb), the corresponding 5-year 
survival rate is 67%; if the cancer has already metastasized to distant sites (stage IV), 
the 5-year survival rate is only 10% [15]. Thus, the disease stage directly affects 
mortality rate in colon cancer. However, only 39% of colon cancer is detected at an 
early stage (stage I/IIa) [8]. Hence, it is of imperative clinical value to develop 
sensitive diagnostic techniques to detect colon cancer at an early stage. In the 
remaining part of this Chapter, the screening methods for colon cancer are briefly 
reviewed and the challenges for conventional screening tests are discussed. 
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1.2  Screening Tests for Colon Cancer 
Patients with colon cancer may present symptoms such as occult or symptomatic 
anemia, bright red blood per rectum, abdominal pain, change in bowel habits, 
anorexia, weight loss, nausea, vomiting, or fatigue. Although the symptoms of colon 
cancer are not inherently unique, the biology of colon cancer provides opportunities 
for preventive strategies to detect at an early stage. The progression from 
premalignant lesions to colon cancer consists of multiple steps, such as development 
of polyps and occult bleeding, which are clinically recognizable. For instance, 
during the colonoscopic examination, the polyps can be found and removed before 
they turn into cancer. Thus, the screening test is a key element for increasing the 
chance of detecting a curable neoplastic lesion and decreasing colon cancer 
morbidity or mortality [16]. In the past 20 years, there are drastic progresses in the 
development of new screening methods for colon cancer [17]. In the next two 
sections, the conventional screening methods and novel techniques will be reviewed, 
including fecal occult blood testing, computed tomography (CT) colonography, 
endoscopic screening, and novel colonoscopes integrated with advanced optical 
techniques.  
1.2.1 Conventional colon cancer screening methods 
Fecal occult blood testing (FOBT) 
FOBTs aim to detect subtle blood loss in the gastrointestinal tract and are often done 
as the part of a routine examination. The cancerous tissue is more likely to bleed 
than normal tissue in the colon due to inflammatory bowel disease, adenomas polyps, 
or benign or cancerous tumors. Thus, microscopic bleeding provides the basis for 
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screening early colon cancer using FOBT. There are two main FOBT technologies: 
guaiac-FOBT (G-FOBT) and fecal immunochemical testing (FIT). G-FOBT is 
dependent on the detection of peroxidase activity of heme, while FIT is based on 
antibodies to detect globin [18]. Since globin does not survive in the passage 
through the upper gastrointestinal tract, the FIT’s detection of globin is specific for 
occult bleeding from the large bowel. Therefore, FIT is more sensitive and specific 
for detection of cancerous and pre-cancerous lesions than the G-FOBT. Moreover, 
FIT does not require dietary or drug restriction prior to testing [19].  
FOBT can be simple and easy to perform in the convenience and privacy at 
home. These advantages for easily undergoing the test could lead to higher rates of 
screening participation. However, the biology of bleeding is complex. Positive tests 
could result from either upper gastrointestinal bleeding or lower gastrointestinal 
bleeding, thus they warrant further investigation for colon cancer or gastric cancer. 
The sensitivity of FOBT is difficult to estimate, but studies of interval cancers 
suggest that only 50% of cancers will be picked up in population screening and the 
specificity is much higher at around 98% [20]. In other words, if the test result is 
negative, no further investigation is needed and the participant is recalled for testing 
in two years. Otherwise, colonoscopy is offered for further investigation [16]. 
Computed tomography (CT) colonography 
CT colonography, which is also referred to as ‘virtual colonoscopy’, is a CT scan x-
ray test to provide a three dimensional radiologic assessment of the colon for large 
colon polyps and cancers. This test has been recommended to people without 
symptoms to screen for colon polyps and cancers. The main advantages of CT 
colonography are considered to have the ability to visualize the whole bowel and 
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localize any lesions with less invasion than conventional colonoscopy [21]. 
The sensitivity for the CT colonography depends on the lesion size. For the 
detection of a 1 cm diameter polyp or even larger size, CT colonography can achieve 
sensitivity around 90%. For polyps less than 1 cm, the sensitivity decrease rapidly; 
the sensitivity is only about 50% for detection of the flat or small lesions (<1 cm) 
[22-23]. Consequently, radiologists are advised not to attempt to interpret polyps 
with 5mm or smaller diameter that are found by CT colonography. Moreover, there 
are additional challenges for the utilization of CT colonography for screening colon 
cancer. First, it is not therapeutic and full bowel cleaning is also necessary. Second, 
the radiologic equipment and imaging software are not widely available. Finally, the 
evaluation of images is time-consuming. Hence, more studies are needed before this 
technique becomes established as a standard screening method.  
Endoscopic screening 
In 1963, the first endoscopy for the colon was introduced by Turell; and since then 
flexible sigmoidoscopy has been used for colon examination in the clinic [24]. 
Currently, endoscopy has become the primary diagnostic and therapeutic method for 
the evaluation and treatment of colonic disease. Sigmoidoscopy and colonoscopy are 
the most common screening procedures.  
A sigmoidoscopy allows an examination of the final 2 feet of the colon, 
reaching 30-60 cm into the colon from the rectum through sigmoid. This 
examination can be conducted without sedation and only with enema preparation. 
The whole procedure for the sigmoidoscopy takes 10 to 20 minutes, and the patient 
does not need recovery facilities. There are two types of sigmoidoscopy: rigid and 
flexible sigmoidoscopy. Flexible sigmoidoscopy is generally the preferred procedure. 
 7
This is because the flexible sigmoidoscope with its 60cm length flexible probe 
allows more comfortable insertion and manipulation around the rectosigmoid 
junction and sigmoid colon compared to the rigid sigmoidoscope. Approximately 
75% of colon cancer occurs in the rectum or sigmoid colon, thus flexible 
sigmoidoscopy has been reported to have 60% to 70% sensitivity for the detection of 
advanced neoplasms and a 60% to 80% reduction in mortality of colon cancer [25-
26]. However, due to the limited probe length, flexible sigmoidoscopy is not 
sufficient to detect polyps or cancer in the ascending or transverse colon. Moreover, 
sigmoidoscopy is less sensitive for adenomas than colonoscopy even in the distal 
colon [27]. 
Colonoscopy, which is the most complete methods for examining the colon, 
has been accepted as the gold standard for the diagnosis of colon cancer. The first 
complete colonoscopy was reported by Wolf in 1971 [28]. With the development of 
light source, flexible shaft, fiber optic, angulation control, and charge coupled 
devices (CCDs), video colonoscope was invented in the 1980s [29]. Currently, the 
conventional white-light reflectance (WLR) colonoscope transmits light to the 
lumen via fiber optics cables from a separate light source, and then retrieves images 
digitally using a CCD chip at the tip with a 140° field of view [30]. Under visual 
guidance, the colonoscopic examination can be used to look for inflamed tissue, 
ulcers, and abnormal growths in the colon and assist doctors in detecting early signs 
of colon cancer. Integrated with the ability to take biopsies and intervene 
therapeutically, colonoscopy is the ideal diagnostic tool for colon cancer. Although 
the sensitivity for the colonoscopy is strongly associated with the operator’s skill, 
the quality of the colon preparation, and the withdrawal time that it takes to examine 
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the entire colon, colonoscopy is more sensitive than sigmoidoscopy for adenoma 
detection. Less than 6% of advanced adenomas (at least 1 cm in diameter) are 
reported to be missed on colonoscopy [31]. A 50% reduction in mortality colon 
cancer was observed in a case control study of colonoscopy in the US veteran 
population [27]. In addition, colonoscopy also showed clear mortality benefit in a 
population of people with hereditary colon cancer [32].  
Colonoscopy has become the established routine procedure for colon disease 
screening. However, there are several limitations that hamper colonoscopy from 
being the primary screening tool for colon cancer, such as the bowel preparation, 
cardiovascular events during sedation, perforation and bleeding, longer time for 
employment, relatively high cost, and the need for trained personnel. Thus, some 
advanced techniques have been developed to complement conventional colonoscopy 
for the non-invasive in vivo detection and diagnosis of colon cancer during 
colonoscopic examination. 
1.2.2 New colonoscopy techniques  
As introduced in the previous section, applying different screening methods for early 
detection of colon cancer is effective to reduce related mortality. FOBT as the first 
step screening has showed a 15-38% reduction on an intention-to-screen basis at the 
population level, while colonoscopy as the second step further provides 
comprehensive adenoma detection. Currently, it is recommended that screening for 
colon cancer begins at 50 years age with annual or biennial FOBT screening and 
every 5 years flexible sigmoidoscopy or colonoscopy. However, the limitations for 
these conventional screening methods, as discussed above, render a demand for new 
colon cancer detection and diagnosis techniques. Here, four representative novel 
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colonoscopy screening methods were selected to demonstrate the improvements in 
the diagnosis of precancer and cancer in the colon. 
Chromoendoscopy 
Chromoendoscopy takes advantage of stains or pigments to enhance mucosal details 
to improve tissue localization, characterization, and diagnosis of colon cancer [33]. 
During colonoscopy screening, the stains can be sprayed using specially designed 
catheters through the instrument channel. Then the effect of these stains on the 
subtle mucosal irregularities can be visualized under a white light colonoscope or 
fluorescence endoscope. The major absorptive dye is methylene blue and  contrast 
agent is indigo carmine [34]. Saitoh et al. reported the successful application of 
chromoendoscopy using 0.08% indigo carmine to improve the diagnosis of flat and 
depressed lesions by 65% [35]. Chromoendoscopy has been shown to be a very 
simplistic method to enhance mucosal detail by spraying of stains, thus it has been 
widely applied in a variety of clinical settings and throughout all gastrointestinal 
tract segments (including the colon) by the endoscope in the past 10 years [36]. 
Chromoendoscopy is perceived to be a safe procedure, and the stains are considered 
to be nontoxic at the concentrations used [37]. However, because of the usage of the 
chemical dyes, the side effect of these chemical stains warrants further investigation. 
Confocal microendoscopy  
Confocal microscopy is a powerful tool to perform high-resolution non-invasive 
imaging of a thin plane or section within a thick turbid biologic tissue [38]. It 
enables the optical sectioning capability for in vivo imaging of tissue with depth 
selectivity and realizes real-time microscopic visualization of tissue at the cellular 
level. As a result, the confocal microendoscope can improve the selection of tissue 
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for biopsy and increase the accuracy of diagnosis. Moreover, it may even replace 
tissue extraction biopsy and realize real-time non-invasive optical biopsy [39]. A 
miniaturized confocal microscopy has been developed by OptiScan and Pentax 
Corporation to incorporate into the distal tip of conventional colonoscopy for 
simultaneous white light endoscopy and confocal microscopy [40]. Based on the in 
vivo subsurface analysis of colonic cellular structures, Kiesslich et al. reported a 
high accuracy (sensitivity 97.4%, specificity 99.4%, and accuracy 99.2%) for 
detecting neoplastic changes during confocal microendoscopy in the colon [40]. The 
successful applications of confocal microendosocopy have demonstrated the 
potential for a non-destructive optical biopsy for performing instantaneous mucosal 
histopathology without the risk of bleeding [41]. Despite the promise of confocal 
microendoscopy technologies, continual technical advances are needed to further 
explore the full potential of confocal microendoscopy for colon cancer detection and 
diagnosis, such as sectioning at greater depths, contrast agents for specific disease, 
and increased frame rates for reducing scanning time.   
Capsule endoscopy 
Capsule endoscopy was developed to examine parts of the gastrointestinal tract that 
cannot be seen with other types of endoscopy. After a patient swallows the capsule 
that contains a tiny camera, images are captured and sent back to a computer for 
construction inside luminal view of entire gastrointestinal tract [42]. Currently, it has 
been successfully used to visualize the upper gastrointestinal tract and small bowel 
[17]. But a few applications have been reported in the colon due to the limited 
battery life. Van Gossum et al. have reported that 73% of advanced adenoma and 
74% of cancer cases are correctly detected by capsule endoscopy compared with 
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conventional colonoscopy [43]. However, capsule endoscopy has not been widely 
explored for detection of colonic lesions. This is due to the impact of gastrointestinal 
motility on the visualization and accuracy of image capture. The slow motility could 
result in slow progress and battery failure before completion of the whole exam, 
while the rapid motility could result in inadequate imaging and poor image quality. 
Moreover, it still lacks the ability to biopsy the detected lesions during the screening 
procedure. Until upon resolution of these issues, capsule endoscopy could provide a 
major advance in the diagnosis of colonic disease.  
Autofluorescence imaging and spectroscopy 
Laser-induced fluorescence spectroscopy and imaging take advantage of 
endogenous fluorophores to improve the detection of microscopic lesions at the 
molecular level during endoscopic examination. Since endogenous fluorophores are 
associated with the structural matrix of tissues or involved in cellular metabolic 
processes, autofluorescence (AF) techniques have been developed to interrogate the 
colonic epithelial surfaces to reveal subtle lesions not seen by conventional WLR 
endoscopy. When the colonic tissues are illuminated by low-power laser, the emitted 
fluorescence light with longer wavelength than the illumination light is the tissue AF 
arising from endogenous fluorophores. Different excitation wavelengths induce 
different groups of fluorophores, each of which emits at a range of different 
wavelengths.  
Fluorescence emission from tissue is not only affected by constitutions of 
fluorophores, but also influenced by tissue architecture, light absorption properties, 
biochemical environment, and metabolic status of the tissue [44]. When cancer 
occurs, the invasion of the cancer cells results in the alteration of tissue 
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morphological structure and biochemical composition. As a result, the tissue AF 
emission changes accordingly. Thus, AF techniques have been explored to 
interrogate cancer in various organs by comparing the differences of AF spectra or 
images between normal and cancer tissues. AF bronchoscopy has become one of the 
well developed techniques for detecting early lung cancer [45]. AF technique has 
also been integrated with conventional WLR colonoscopy for detecting 
premalignant lesion in the colon [46]. A clinical study has reported the successful 
application for differentiating benign hyperplastic polyps from adenomatous polyps 
with a sensitivity of 90% and a specificity of 95% [47]. To date, tissue fluorescence 
was one of the best developed methods to enhance the conventional endoscopic 
diagnosis of gastrointestinal lesions [48]. In Chapter 2, the principle of tissue 
fluorescence will be further introduced, together with the application of fluorescence 
imaging and spectroscopy for detection of precancer and cancer in the colon.  
1.3  Challenges for Colonoscopy Screening  
To date, colonoscopy is the accepted gold standard for the screening and 
surveillance of colon cancer. In general, the diagnosis of colon cancer is based on 
conventional WLR colonoscopic inspections followed by the histopathological 
examination of biopsied tissues. However, the conventional WLR colonoscopy 
heavily relies on the observation of gross morphological changes of tissues. As a 
result, the flat and depressed neoplastic lesions, which have strong potential to 
develop early submucosal invasion, are difficult to identify due to the lack of 
obvious morphological changes. A recent study reported a 4.0% miss rate during 
colonoscopy for detecting cancer in usual clinical practice and further highlighted 
the fact that colonoscopy techniques require further refinement [49]. Hence, it is 
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highly desirable to develop advanced diagnostic techniques to complement WLR 
endoscopy for improving the non-invasive in vivo detection and diagnosis of colon 
cancer. As introduced in the previous section, combining different technologies and 
integrating them into a multifunctional endoscope would offer new optical features 
in colonoscopy and improvement for cancer diagnosis. 
This thesis focuses on developing a near-infrared (NIR) AF spectroscopy and 
imaging system to complement conventional white light colonoscopy. We develop a 
novel polarized NIR AF and diffuse reflectance (DR) imaging system to improve the 
early detection of colon cancer. Moreover, we explore an endoscope-based NIR AF 
spectroscopy system to realize real-time in vivo NIR AF spectra measurements 
during clinical colonoscopic examination.   
1.4  Thesis Organization 
This thesis is organized as follows. Chapter 2 first reviews the theory of 
fluorescence imaging and spectroscopy techniques and then introduces the clinical 
applications of fluorescence imaging and spectroscopy for detection and diagnosis 
of cancers in different organs. It also presents the research motivations and 
objectives. 
Chapter 3 elaborates on the development of a novel polarized NIR AF 
imaging system for tissue measurements. Specifically, it presents the application of 
the integrated polarized NIR AF imaging system combined with NIR DR imaging 
for colon cancer detections.  
Chapter 4 explores the endoscope-based NIR AF spectroscopy system for 
real-time in vivo identification of colonic polyps during colonoscopic screening. 
Multivariate statistical techniques (principal components analysis (PCA) combined 
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with linear discriminate analysis (LDA)) are employed for classification of subtypes 
of colonic polyps. 
Chapter 5 investigates the origins of endogenous fluorophores for NIR AF 
from colonic tissue by using a non-negativity-constrained least squares minimization 
(NNCLSM) biochemical model.  
Chapter 6 implements the integrated visible (VIS) and NIR DR spectroscopy 
for improving colon cancer diagnosis. 
Finally, conclusion and discussion on future directions are presented in 
Chapter 7. 
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Chapter 2 Fluorescence Imaging and Spectroscopy 
This Chapter serves to introduce the research motivations and objectives of the 
thesis. The necessary principal knowledge and concepts for developing fluorescence 
technique to detect precancer and cancer in the colon are presented first. As some 
related works are also the rudimentary elements of the proposed researches, this 
Chapter reviews the development of fluorescence spectroscopy and imaging in 
clinical diagnosis.  
2.1  The Basis of Fluorescence 
2.1.1 Interaction of light with a molecule 
Fig. 2.1 shows that light is a form of electromagnentic radiation, consisting of an 
oscillating electric field with an oscillating magnetic field perpendicular to it [50]. 
When a molecule is placed in an oscillating electric field like light, it will experience 
a pushing and pulling force. At the same time, the molecule could oscillate at 
specific resonant frequencies that are related to its states. Each state of the molecule 
is associated with the energy level, which  can be demonstrated by a diagrammatic 
way called the Perrin-Jablonsk diagram [51]. If the molecule oscillates in synchrony 
with the oscillating field, the molecule can absorb energy from the field. Since the 
energy of the light is proportional to its frequency, a given molecule will absorb a 
specific set of wavelengths of light. The range of wavelength absorbed by valence 
electrons varies from about 1000 nm (near infrared) through the visible (VIS) and 
ultraviolet (UV) down to about 100 nm (far UV). 
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Fig. 2.1 Electromagnetic waves with the electric field in a vertical plane and the 
magnetic field in a horizontal plane [52]. 
 
When a molecule absorbs the energy from the oscillating field, the electron 
cloud of the molecule would redistribute, and then cause the changes of dipole 
moment and shape of the molecule. Since electronic absorption is often 
accompanied by vibrational motion as the atoms move to their new positions, the 
molecule bonds alter. Consequently, the energy state of the molecule could move 
into the excited states from the ground states. However, the excited states of 
molecules are unstable and they relax (lose their energy) by a number of 
mechanisms, such as collisions with other molecules or reactions with other species. 
The excited molecule may also relax by emitting a photon of light to return to a 
lower state, though not always the same lower state from which it came. The emitted 
photon will have an energy corresponding to the difference in energy between the 
initial and final states of the molecule. The emission of a photon is known as 
fluorescence or in some cases phosphorescence.  
Fig. 2.2 illustrates the Perrin-Jablonski diagram describing the transitions 
responsible for absorption, fluorescence, and phosphorescence interactions. 
Molecules are always in their ground state (S0) at room temperature. When a 











matches one of the available energy-level transitions, the molecule would move into 
a higher energy state, such as the excited singlet state (S1) and the lowest excited 
triplet state (T1). Fluorescence occurs when the molecules return to S0, from the 
excited singlet state such as S1, by emission of a photon. The process happens 
readily and quickly with the result that excited electronic states survive only for a 
very short period of time, typically a few nanoseconds, before emitting. A molecule 
in T1 could also lose by emission of a photon to return to S0 and then we have 
phosphorescence. Molecules are continuously interacting with their surroundings to 
transfer vibrational energy to the surrounding molecules. This vibrational energy 
transfer process is named the vibrational relaxation (VR) or thermalization. It occurs 
in both the ground and excited electronic states. Vibrational relaxation can lead 
reaction of cold molecules or de-excitation of hot molecules, until both of them 
reach thermal equilibrium. Thus, the measurements of tissue absorption, 
fluorescence, and phosphorescence could provide biochemical information 
associated with changes in electronic energy states [53]. 
 
Fig. 2.2 Simplified Perrin-Jablonski diagram showing three electronic states, 
several vibrational states, absorption of electromagnentic radiation, and emission 













2.1.2 Properties of fluorescence 
Fluorescence is defined as the radiative transition between two electronic states of 
the same spin multiplicity [55]. It is a luminescence in which the molecular absorbs 
a photon and triggers the emission of another photon with a longer wavelength [56]. 
Fluorescence occurs when an orbital electron of a molecule relaxes to its ground 
state by emitting a photon of light after being excited to a higher quantum state by 
some type of energy [57], expressed as 
Excitation: 10 ShvS ex →+ ,                                            (2.1) 
Fluorescence (emission): heathvSS em ++→ 01 ,                      (2.2) 
where hv  is a generic term for photon energy: h  is the Planck's constant and v  is 
the frequency of light, 0S  is the ground state of the fluorescent molecule and 1S  is 
its first excited state. Besides fluorescence, the excited molecule can also relax by 
various competing pathways. For example, the excitation energy can be dissipated as 
heat (vibrations) to the solvent by non-radiative relaxation or converted to a triplet 
state which may subsequently relax via phosphorescence.  
2.1.3 Fluorescence polarization [56, 58-59] 
Fluorescence polarization was first described by Perrin in 1926 [60] and then greatly 
developed for the application in biological systems. It is based on the observation of 
the molecular orientation and mobility using polarized light. If excited with 
polarized light, the fluorescence emission from samples is also polarized. 
Polarization is a general property of fluorescent molecules. 
When excitation light is polarized, the absorption of the fluorophores will 
depend on the orientation of its dipole in the ground state compared to the polarized 
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excitation light. Fluorophores with dipoles, which are perpendicular to excitation 
light, cannot absorb the energy of polarized excitation light; fluorophores with 
dipoles that are parallel to excitation light will absorb the most. Thus, polarized 
excitation will induce the photon selection for the fluorophore absorption. The 
emitted fluorescence is measured with an analyzer. When the emission is parallel to 
the excitation, the measured intensity is called ||I , while when the emission is 
perpendicular to the excitation light, the measured intensity is ⊥I . Fluorescence 









||                                                      (2.3) 
Since the presence of the analyzer induces photon selection, the global 
fluorescence intensity that is recorded in the presence of the analyzer is lower than 
that obtained in its absence. This is a consequence of the decrease in the number of 
absorbing and emitting fluorophores. The polarization unit is a dimensionless entity. 
According to Equation (2.3), the value of P does not depend on the intensity of 
emitted light and the fluorophore concentration. But the reality is quite different. The 
values of P occur between -1 ( ||I =0) and 1 ( ⊥I =0). Natural or unpolarized light, 
where ||I = ⊥I , yields a P value of 0. These two extreme values of P are observed 
when the polarized absorption transition moment and that of the emission are 
perpendicular ( ||I =0) or colinear ( ⊥I =0).  
Fluorescence polarization is a technique specially applied to study molecular 
interactions. The use of polarized light measurements has been well developed to 
characterize cells and tissues in medicine and biology [61-62]. The interactions of 
polarized light and tissue, such as scattering, offer a mechanism of gating or 
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selecting the photons. The back reflectance light from the initial tissue layer, which 
scatters back out of the tissue by one or two single scattering events, retains the 
linear polarization to the incident light. The remaining incident light continues to 
penetrate into the deeper layer and the orientation of polarization becomes 
randomized due to the multiple scattering events. At last, approximately half of this 
deeply penetrating light is absorbed and another half of this randomly polarized light 
is backscattered to the surface. Thus, the fluorescence polarization has the ability to 
selectively probe the emitted photon that arises from different depth of the tissue.    
2.1.4 Fundamentals for fluorescence detection  
The basic measurement of fluorescence requires a light source that matches the 
absorption spectrum of the molecule and a detector to monitor the emitted 
fluorescence. A fluorescence emission spectrum is a plot of the magnitude of the 
emitted fluorescence as a function of its wavelength. In biology and medicine 
application, fluorescence emission generally occurs from organic molecules, which 
are called fluorophores. Fluorophores can be used as a natural indictor to study the 
structure, dynamics, and metabolism of living cells. Each fluorophore has it own 
specific fluorescence properties that are dependent on its structure and the 
surrounding environment (e.g., temperature, pH, polarity, and oxidation state). As 
such, these characteristics make fluorescence techniques ideal tools in the 
measurement of tissue for clinical diagnosis.  
Biological tissues are optically turbid. At a microscopic level, tissue can be 
considered as a scattering and absorbing center with random distribution [63]. 
Scattering and absorption affect both the excitation light fluence rate in tissue and 
the amount of excitation or fluorescence light that leaves the tissue [64]. The 
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scattering is usually assumed to be caused by tissue constituents with different 
refractive index. When light propagates through the tissue, these scatterers would 
introduce small changes in the direction of the light. Although the scattering is 
highly forward directed and the direction changes are small, multiple scatter events 
will produce significant effects on the light distribution in the tissue [65]. Both 
exogenous and endogenous chromophores can absorb the energy of the incident 
light and re-emit fluorescence at longer wavelengths. Hence, based on the measured 
the fluorescence light emitted from the tissue, we can interrogate the interactions 
between the excitation light and the tissue. 
Fig. 2.3 depicts the light-tissue interaction that takes place when the 
fluorescence emission is measured. Monochromatic light is incident on the tissue 
surface. This light scatters within the tissue, where it can either be absorbed or 
diffusely reflected from the tissue surface. The remaining lights propagate into the 
tissue media. Some will go out after multiple scattering in tissue and some will be 
absorbed. The absorbed light can be converted to fluorescence. This fluorescent light 
continues to scatter in the tissue, where it can either be reabsorbed or emitted from 
the tissue surface. As a result, the emitted fluorescence contains contributions not 
only from tissue fluorophores, but also from absorbers and scatters. In addition to 
interaction with these tissue constituents, reflection and refraction may also take 
place at the interface between the tissue and the exterior medium due to differences 
in refractive index [66]. All of these chromophores can have wavelength-dependent 
signatures that affect the measured fluorescence spectrum. Thus, to understand the 
changes in tissue fluorescence spectra that are associated with certain disease, we 
must examine changes in all types of chromophores.  
 22
 
Fig. 2.3 Interactions between tissue and light. 
 
There are three important types of chemical groups that interact with light in 
tissue: fluorophores (chemical groups that can convert absorbed light to 
fluorescence), absorbers (chemical groups that absorb light but do not produce 
fluorescence), and scatterers (structures that change the incident photon direction but 
conserve it energy) [57]. The optical properties of each type of chromophores may 
depend on both wavelengths and tissue types.  
Fluorophores 
Fluorophores are a functional group of molecules that will absorb energy of a 
specific wavelength and emit energy at different wavelengths, such as connective 
matrix (collagen, elastin), cellular metabolic coenzymes (reduced nicotinamide 
adenine dinucleotide (NADH), flavin adenine dinucleotide (FAD), and flavin 
mononucleotide (FMN)), aromatic amino acids (tryptophan, tyrosine, and 
phenylalanine), byproducts of the heme biosynthetic pathway (porpyrins), and 
lipopigments (lipofuscin, ceroids) [34]. Each group of fluorophores is characterized 










Absorbers also affect fluorescence spectra measured in tissue since the emitted 
fluorescence can be reabsorbed while exiting the tissue. Fig. 2.4 shows examples of 
primary absorption spectra of some biological tissues. In the UV and VIS regions of 
the spectrum, the absorption increases with shorter wavelength mainly due to 
proteins and hemoglobin. In the red to near-infrared (NIR) regions, absorption is 
minimal. Thus, this region suits for diagnosis and therapy. In the infrared region, the 
absorption increases with longer wavelengths due to tissue water content.  
 
Fig. 2.4 Absorption spectrum for some tissues (aorta, skin) and tissue components 
(whole blood, melanosome, epidermis, and water) [67].  
 
Scatters 
Due to the intense scattering of tissue, light can propagate into tissue, enabling one 
to extract information noninvasively from this volume of tissue [65]. The elastic 
tissue scattering arises from the microscopic heterogeneities of refractive indices for 
cells with complex structure. The laser penetration depth depends on the wavelength; 
the longer the light wavelength scatters less and penetrates deeper into the tissue. 
The exceptions are laser wavelengths above 1300 nm, which hardly penetrate into 
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the tissue due to the high absorption by the tissue water. VIS light can propagate 
from 0.5 to 1.0 mm, while the red and infrared laser light have the highest 
penetration depth from up to 3 mm [55].  
2.2  Application of Fluorescence in Clinical Diagnosis 
An increasing number of fluorescence technologies are available for the detection 
and diagnosis of diseases, such as fluorescence microscopy, autofluorescence (AF) 
endoscopy, and exogenous fluorescent contrast agents [68-71]. There are several 
advantages of fluorescence measurements for clinical diagnosis [72]. First, 
fluorescence is characterized by high sensitivity allowing concentrations of 
biomolecules to be measured down to as low as 10-18 M (attomole); the 
measurements are also fast. Second, fluorescence is affected by different types of 
fluorophores, absorbers, and scatters. Hence it is capable of investigating subtle 
changes of disease progression, such as concentration of metabolites, tissue structure, 
cellular orientation, and distances between molecules. Moreover, fluorescence is 
also sensitive to the chemistry of the environment (e.g. pH, ionic strength, and 
fluidity), and thus, it can also be applied for studies where the disease changes the 
chemistry of the environment. At last the products of fluorescence and fluorescence 
itself are safe for tissue diagnosis; there is little or no alteration in sample structure. 
Hence, fluorescence measurements are ideal for in vivo studies and studies of living 
tissues.  
Currently, there are two major approaches of fluorescence-based techniques: 
exogenous contrast agents and AF. The first approach relies on the presence of 
exogenous contrast agents. For the exogenous fluorophores, both organic and 
inorganic fluorescence contrast agents are now available for chemical conjugation to 
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target molecules. In contrast, AF technique relies on endogenous molecules within 
the tissue. Based on the subtle changes in the tissue composition and morphology 
associated with disease transformation, tissue AF can be used for the detection of 
diseased tissues.  
2.2.1 Exogenous fluorescent contrast agents 
To date, the exogenous fluorescence contrast agents have been largely exploited to 
selectively localize the suspicious lesions with photosensitizers for photodynamic 
therapy. With drug-induced fluorescence, the signal is much stronger than tissue AF. 
Thus, the contrast between tumor and surrounding normal tissue could be highly 
enhanced. Nonspecific fluorochromes are often used as contrast agents, such as 
indocyanine green (ICG, cardiogreen). ICG has been approved for the use in 
indicator-dilution studies in humans since 1958 [73]. It is one of the least toxic 
agents ever administered to human. ICG absorbs NIR light and emits fluorescent 
light at a wavelength of 780 nm and 830 nm [74]. It has been widely used in clinic 
and experimental studies, such as vascular mapping, angiograms of the eye, and 
adenocarcinoma detection in different organs [75]. However, the conventional 
organic exogenous contrast agents suffer from significant limitations[76]. First, it is 
difficult to control excitation wavelengths, which are dependent on chemical 
structure. Tuning a conventional fluorophore to precise wavelengths needs highly 
complicated chemistry and the molecules are potentially unstable. Second, it suffers 
from lower quantum yield. The quantum yield for the organic contrast agents is 
usually less than 15% in aqueous environment [75]. Moreover, the conventional 
contrast agents are highly susceptible to photobleaching, which limits the fluence 
rate for sample and further affects the sensitivity for detection.  
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In contrast, inorganic fluorescent semiconductor nanocrystals, also called 
quantum dots (QDs), have the potential to solve problems that limit the application 
of organic contrast agents. QDs are synthesized in organic solvents and typically 
comprise an inorganic core and inorganic shell of metal. Due to such special 
structure properties, the fluorescence emission for QDs can be tuned to specific 
peaks of discrete wavelength [75]. Moreover, QDs can be excited with a single 
wavelength and emit at several different wavelengths. Thus, they are suitable for 
multiplex detection of multiple targets in a single experiment. With the unique 
optical properties, QDs have been explored for in vivo fluorescence imaging to 
provide direct visual guidance for minimizing incision and dissection inaccuracies 
and realize real-time confirmation of complete resection [77-78]. However, because 
of the multi-layered structure, QDs are typically large in diameter and difficult to 
clear from the circulation. The in vivo toxicity of QDs remains unknown. Hence, the 
studies of QDs still focus on the animal’s models. Currently, the medical usage of  
gold nanoparticles in the human body has been approved by the Food and Drug 
Administration (FDA) [79]. 
2.2.2 Autofluorescence 
The second type of fluorescence-based diagnostic technique is AF, which relies on 
subtle changes in the tissue composition and morphology to help localize diseased 
tissue without using any exogenous contrast agents [80]. In diagnostic applications, 
AF techniques exhibit both advantages and disadvantages. AF is characterized by 
signal amplitude and a lower spectral selectivity than those of exogenous 
fluorescence induced by contrast agents. It has relatively low quantum efficiency 
and suffers from the overlapping of both the excitation and emission spectra of 
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several endogenous fluorophores that coexist in the tissue. On the other hand, AF 
provides real information of the biological substrate since it is directly related to the 
biomolecules in their natural environment without any perturbation of exogenous 
substances. Thus, AF has the great advantage of real-time monitoring the changes of 
the endogenous fluorophores in different physiological pathological or experimental 
conditions. In 1938, AF was first investigated by microscopy [81]. With the 
advancements in the fields of excitation sources, light delivery systems and sensitive 
detection devices, as well as a better knowledge of the endogenous fluorophores, AF 
has been applied in characterization of biology tissues. Over the past two decades, 
AF technology has been integrated into endoscopy to probe the biochemistry of 
epithelial surfaces, revealing the presence of disease not seen by conventional white-
light endoscopy [82].  
The AF of biological tissues arises from endogenous molecules within the 
tissue. These biomolecules are called fluorophores, which are responsible for the 
tissue’s morphological structure or involved in the metabolic and functional 
processes of cells. For instance, collagen and elastin are the representative of 
structural proteins in the extracellular matrix of connective tissue; reduced 
nicotinamide adenine dinucleotide (NADH), flavin adenine dinucleotide (FAD), and 
flavin mononucleotide (FMN) are the enzymes, which are typically involved in 
metabolism; aromatic amino acids (tryptophan, tyrosine, and phenylalanine) are 
used to synthesize the protein in the human body; porphyrins are the by-products of 
heme biosynthesis [34]. When cells are in disease states, they often undergo 
different metabolism rates or have different structures compared to those in normal 
conditions. These changes in the morphological and biochemical properties of cells 
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and tissues could alter the concentration and distribution of the endogenous 
fluorophores and further affect the autofluorescence properties. Hence, AF can 
provide a significant amount of information about the morphological structure and 
metabolic processes associated with the disease progression. The endogenous 
fluorophores have been used as a specific marker for biological processes and AF 
has become an intrinsic biological parameter to track disease development.  
In general, the fluorescence emission bands are often broad, relatively 
featureless, and overlap with one another. This is because a single excitation 
wavelength could excite many fluorophores. Consequently, the emission signals may 
overlap many fluorophores since the absorption and emission bandwidths of these 
molecules can be broad. Tissues have a mixture of several fluorophores that occur in 
different concentrations and at different depths. The overall AF emission of a tissue 
is strictly dependent on at least one of the following parameters [56]: the fluorophore 
concentration, spatial distribution throughout the tissue local microenvironment, and 
the particular tissue architecture. In addition, the fluorescence characteristics of a 
biological tissue also depend on the tissue optical properties. The concentration and 
distribution of non-fluorescent absorbers and scatterers within the tissue will affect 
the propagation of the light (both excitation and emission), influencing the signal 
amplitude and the spectral shape of the AF spectrum.  
To date, AF technique has been widely applied for diagnosis in oncology. 
During the progression of cancer, AF properties of tissues will be affected by the 
alterations of both morphological structure and metabolic activity [83]. For colon 
cancer, the proliferation of neoplastic cells causes the thickening of the mucosa layer, 
and this histological alteration results in a strong decrease or loss of the contribution 
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of brightly fluorescing collagen and elastin from the normal submucosa [84]. As a 
result, colonic cancer tissue has a reduction of fluorescence emission compared to 
the normal tissue [84]. Therefore, the difference of tissue AF can be used to identify 
the early colon cancers or premalignant lesions from normal tissues.  
AF spectroscopy and imaging have been intensively studied to improve the 
detection and localization of early cancer in different organs, including the cervix, 
bladder, lung, breast, esophagus, stomach, uterus, skin, and colon [85-89]. Tissue AF 
has also shown promise in other clinical applications such as the diagnosis of 
atherosclerosis [90] and Alzheimer’s disease[91]. AF bronchoscopy is one of the 
successfully developed techniques that significantly improve the sensitivity for 
detection of early lung cancer. It is performed and evaluated as an adjunct to the 
white light bronchoscopy for detection of lung cancer. When the bronchial surface is 
illuminated by violet or blue light, normal tissue emits strong fluorescence in the 
green, while dysplasia, carcinoma in situ, and invasive cancer have decreased AF 
emissions [92]. A number of commercial AF bronchoscopy devices have been 
developed to improve conventional white light bronchoscopy [93]. The relative 
sensitivity of AF bronchoscope versus white-light examination alone is found to 
increase by an average of two-fold in detecting high-grade dysplasia and carcinoma 
in situ [94]. As the latest advancement in this field, an integrated endoscopy system 
for simultaneous imaging and spectroscopy (OmniScope) has been developed to 
improve the specificity of AF bronchoscope while maintaining high sensitivity [95].  
2.2.3 Near-infrared autofluorescence 
In vivo fluorescence measurement of tissues is significantly wavelength dependent 
and the used excitation and emission wavelengths determine the dominant 
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fluorophores that are involved. This is because the different excitation wavelengths 
can activate different groups of fluorophores, each of which emits at a range of 
different wavelength. Currently, most tissue spectroscopy studies center on the use 
of UV or VIS wavelength (250-550 nm) as excitation light for cancer detection in 
various organs including the colon [87, 96]. When using excitation light with UV or 
VIS wavelength, the light will be highly absorbed by endogenous chromophores in 
tissue and the transport of light is exponentially attenuated according to the Beer-
Lambert law [55]. Due to their shorter excitation wavelengths, the laser light can 
only penetrate limited depth and extract information from superficial tissue layers. 
Unlike the UV and VIS light, NIR light (700-1000nm) is able to penetrate deeper in 
the tissue due to less absorption and scattering from the water and tissue. Moreover, 
NIR light is non-carcinogenic and it is safe for tissue diagnosis. Thus, NIR AF 
technique has the promising potential for the non-invasive in vivo detection of 
lesions located deeper inside the tissue. With the development of highly sensitive 
detectors, monochromatic light sources (lasers) with safe levels of power per 
wavelength, and the study of fluorophores in the NIR region, NIR AF technique has 
been applied for detection and diagnosis of cancer [97-100].  
Demos et al. utilized long-wavelength laser excitation in the green and red 
spectral region to study various types of normal and malignant human tissues 
including breast, liver, kidney, pancreas, prostate, and bladder tissues [101]. The 
experimental results indicated that the AF intensity of cancer tissues were 
considerably different from those of normal tissues. The differences of NIR AF 
intensity between normal and cancer tissue can be attributed to the concentration 
changes of endogenous fluorophores, such as porphyrin productions. Porphyrins, 
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which exhibit absorption in the red spectral region and emit in the NIR and far-red 
region, are assumed to be responsible for the NIR AF emissions in tissues [102]. But 
the origins of the other endogenous fluorophores are still not well understood, which 
warrant further investigations.  
Besides the cancer detection, NIR AF has also been applied to detect brain 
diseases [91, 103-104]. Hanlon et al. demonstrated the investigation of NIR 
fluorescence spectroscopy for the detection of Alzheimer’s disease in vitro [91]. 
Both the excitation light used and the resulting tissue AF were at NIR wavelengths, 
which can propagate through the skull and overlying tissue. Thus, NIR AF technique 
has the clinical potential to realize non-invasive diagnosis of Alzheimer’s disease in 
living patients. Moreover, NIR light has also been used for the functional mapping 
of the cerebral cortex, and further explored to develop a novel and non-invasive NIR 
imaging brain-computer interface system [104].  
However, to date, there are few studies on applying NIR AF technique for 
the early detection of colon cancer. Based on the theory of fluorescence and 
successful application of NIR AF technique, we extend the previous UV/VIS work 
to the NIR domain for the early detection of precancer and cancer in the colon. 
2.3  Motivations 
The motivations for this thesis are summarized as follow: 
1) The endoscopy combined with biopsy is accepted as the gold standard for 
cancer detection and diagnosis. However, conventional white light 
colonoscopy heavily relies on the gross morphological tissue changes, and 
thus, it suffers from low sensitivity of detection for subtle changes in the 
colonic mucosa epithelium. Moreover, biopsy is invasive and has the risk for 
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serious complications. Hence, it is necessary to develop advanced optical 
diagnostic techniques to complement conventional endoscopy for improving 
the diagnosis of precancer and cancer non-invasively.  
2) AF technique, which is capable of probing the changes of both tissue 
morphological structures and concentration of endogenous fluorophores, has 
been widely applied for the diagnosis of cancer in different organs. However, 
the majority of these studies are using the UV or VIS wavelength light for 
excitation, which limits the penetration depth for detecting the suspicious 
lesion located in the deep layer of the tissue. Compared to UV and VIS, NIR 
light is non-carcinogenic and safe for tissue diagnosis, and both the 
excitation light used and the resulting tissue are at NIR wavelengths that can 
penetrate deeper into the tissue up to 1 mm. Hence, it is highly desirable to 
develop robust NIR AF spectroscopy and imaging system for the clinical 
detection and diagnosis precancer and cancer. 
3) Polarized light would be a good tool to study different types of molecule 
rotations. The molecular global rotation and local dynamics are dependent on 
the tissues structure, surrounding environment, and metabolic function of the 
system. As a result, these motions differ from the normal tissue to diseased 
tissues due to the changes of morphology and biochemical composition. If a 
molecule is illuminated with polarized light, the fluorescence emission will 
also become polarized. Consequently, the polarized AF emission has 
capability for cancer diagnosis and characterization. However, because of the 
comprehensive mechanism, the potential of polarized NIR AF techniques for 
clinical cancer detection has not been fully explored. 
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4) The early diagnosis and removal of premalignancies (e.g., adenomatous 
polyps) have been widely accepted for effective prevention colon cancer 
development and decreasing the associated mortality rate. However, the 
subtle macroscopic differences among subtypes of colonic polyps may not be 
apparent under WLR endoscopic imaging. Hence, all polyps found during 
colonoscopy are routinely resected and sent for histopathological 
examinations. The removal of polyps without malignancy potential (i.e., 
hyperplastic polyps) could incur additional time, costs, and risks. Therefore, 
there is an urgent need to develop non-invasive, sensitive, and advanced 
optical diagnostic techniques that improve the differentiation of adenomatous 
polyps from hyperplastic polyps.  
5) NIR AF clinical applications have been limited not only by the difficulty in 
capturing inherently weak tissue NIR AF signals, but also by relatively less 
knowledge of possible endogenous fluorophores responsible for tissue NIR 
AF emission. The investigation of these endogenous fluorophores, which are 
associated with the structural matrix of tissues or cellular metabolic 
processes, could be advantageously helpful to understand the origins of the 
tissue AF in the NIR region and interpret the changes of AF emission at 
molecular level.  
6) DR spectroscopy in the VIS range has been widely investigated in several 
applications related to diagnosis, prognosis, and assessing treatment response 
of cancers in different organs. The integrated VIS and NIR DR spectroscopy, 
which contain both hemoglobin and water signatures, has not be well studied 
for improving the diagnosis of colon cancer. 
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2.4  Research Objectives 
The main aims of this research are summarized as follows: 
•  We develop the polarized NIR AF imaging system for improving the 
detection and diagnosis of colon cancer. 
• We explore endoscopy-based NIR AF spectroscopy to realize in vivo 
differentiation of colonic adenomatous polyps during clinical colonoscopic 
examination. 
• We investigate the endogenous fluorophores for tissue NIR AF emission by 
using the non-negativity-constrained least squares minimization (NNCLSM) 
biochemical modeling. 
• We implement the integrated the VIS/NIR DR spectroscopy for improving 
the detection and diagnosis of colon cancer. 
The specific objectives of this research are itemized as below: 
1) We develop a novel integrated NIR AF and NIR diffuse reflectance (DR) 
imaging system for the detection of colon cancer. The experimental results 
demonstrate the potential of NIR AF imaging technique for improving cancer 
detection compared to conventional white light reflectance imaging method. 
2) We also propose the polarized NIR AF imaging technique to further improve 
the capability of NIR AF imaging for cancer diagnosis and characterization. 
The polarization technique is employed to selectively probe the AF light 
photons that arise from the subsurface or deep areas of tissue. Moreover, the 
depolarization imaging (i.e., the ratio of the difference between parallel-
polarization image (Ipal) and perpendicular-polarization image (Iper) to the 
sum of Ipal and Iper) is explored to improve the contrast between normal and 
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cancer tissue.  
3) We further apply the ratio imaging of white light images to AF images under 
different polarization conditions to eliminate the geometric effect of imaging 
measurements for achieving the best diagnostic accuracy.  
4) We couple a novel bifurcated flexible fiber-probe into our endoscopy-based 
fluorescence spectroscopy to realize in vivo NIR AF tissue measurement at 
colonoscopy.  
5) We evaluate the diagnostic efficacy of NIR AF spectroscopy in conjunction 
with multivariate statistical technique (i.e., principal components analysis 
(PCA) and linear discriminate analysis (LDA)) for the rapid and non-
invasive in vivo identification of precancer in clinical colonoscopic 
examination. 
6) We investigate the endogenous fluorophores in the NIR range by utilizing 
NNCSLM biochemical modeling. We reconstruct fitting spectra by using 
basis reference spectra from the representative biochemicals (i.e., collagen I, 
elastin, β-NADH, FAD, L-tryptophan, hematoporphyrin, 4-pyridoxic acid, 
pyridoxal 5’-phosphate, and water) to compare the in vivo spectra acquired 
from colonic tissues and study the biochemical changes associated with the 
cancer progression.  
7) We explore the integrated VIS-NIR DR spectroscopy for colonic tissue 
measurements and compare the diagnostic performance of VIS, NIR, and the 
integrated VIS-NIR DR spectra.   
 36
Chapter 3 Autofluorescence Imaging of Colonic 
Tissues 
3.1  Introduction 
At present, screening of high-risk populations remains the most pragmatic approach 
for control the development and progression of colon cancer. In general, the 
diagnosis of colon cancer is based on conventional white-light colonoscopic 
inspections followed by the histopathological examinations of biopsied tissues. 
However, the conventional white light reflectance (WLR) colonoscopy, which is 
accepted as the gold standard method for screening and surveillance of colon cancer, 
heavily relies on the observation of gross morphological changes of tissues. The new 
colonoscopy techniques, which have been introduced in the section 1.2.2, have 
shown the potential to complement conventional WLR colonoscopy to improve the 
non-invasive in vivo detection and diagnosis of early cancer in the colon.  
Among these techniques, autofluorescence (AF) is the promising approaches 
that is capable of probing the changes of tissue morphological structures and 
intrinsic fluorophores, such as collagen, nicotinamide adnine dinucleotide (NADH), 
and flavin adenine dinuccleotide (FAD) in the tissue [30, 80, 92, 105-107]. Thus, AF 
technique has been developed to complement conventional endoscope and the light-
induced AF endoscopic imaging can be used to reveal subtle lesions which cannot be 
detect by WLR endoscope. In the past two decades AF imaging has been 
comprehensively investigated for improving the diagnostic sensitivity of malignant 
lesions in various organs, including the colon [46, 80, 92, 96, 106-110]. The video 
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endoscopy system combining with the AF technique has been developed for 
screening in the upper gastrointestinal tract [46, 111]. 
But to date, most of AF studies focus on the utilization of ultraviolet (UV) or 
short visible (VIS) wavelengths as excitation light and suffer from a limited 
penetration depth. Unlike UV excitation light, the near-infrared (NIR) light is non-
carcinogenic, and it is safe for tissue diagnosis [91, 112-114]. Both the excitation 
light used and the resulting tissue AF are at NIR wavelengths that can penetrate 
deeper into the tissue up to 1 mm [112-113]. Hence, NIR AF could potentially be 
useful for the non-invasive in vivo detection of lesions located deeper inside the 
tissue. In this chapter, we extend the previous UV/VIS AF work [46, 96, 109-110, 
115] to the NIR domain for ex vivo colonic tissue diagnosis and characterization. 
We examine if colonic tissue exhibits observable NIR AF under the 785 nm laser 
excitation. Moreover, polarization technique is integrated into NIR AF imaging 
system to evaluate that if the integrated NIR AF imaging and NIR diffuse reflectance 
(DR) imaging with polarization technique can be used for improving colon cancer 
detection and diagnosis. The ratio imaging of NIR DR image to NIR AF image is 
used to eliminate the geometric effect of the imaging measurement and the 
depolarization imaging is expected to improve the contrast between normal and 
cancer tissues. 
3.2  Experiments 
3.2.1 Near-infrared autofluorescence imaging system 
Fig. 3.1 shows a schematic diagram of the integrated NIR AF and DR imaging 
system developed for ex vivo measurements of colonic tissues. A 785 nm excitation 
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light from a diode laser (maximum output: 300 mW, B&W Tec Inc, Newark, DE) is 
coupled into a 200 μm fiber and delivered into a collimator (F220SMA-B, Thorlabs, 
Newton, NJ) for excitation.  The laser beam passes through a narrow band-pass (BP) 
filter (LL01-785-12.5, Semrock Inc. Rochester, NY) to remove interference of fiber 
background fluorescence and laser noise. Then the filtered laser light is reflected by 
a dichroic mirror (Reflection: 450-800 nm, Transmission: 800-1400 nm; Semrock 
Inc., Rochester, NY) and shine onto the tissue specimen. The induced AF emission 
from tissue passes through the dichroic mirror and a 850 nm long-pass filter 
(FEL0850, Thorlabs, Newton, NJ). Finally, the tissue AF signals are collected by an 
NIR-optimized back-illuminated, deep-depletion charge-coupled device (CCD) 
detector (Cascade II 512, Photometrics, Tuscon, AZ) within 8.2×8.2 mm image area. 
With the highest available quantum efficiency (>90% peak QE) of our back-
illuminated EMCCD, the weak NIR AF images can be captured. For the NIR DR 
imaging, a tungsten halogen light (HL-2000, Ocean Optics Inc., Dunedin, FL) is 
coupled into a 200 μm fiber and passes through a beam expander to illuminate the 
tissue directly. The NIR DR photons from the tissue are collected by the CCD after 
passing through the dichroic mirror and the 850 nm long-pass filter. To integrate 
polarization technique into the NIR AF imaging system, two linear polarizers (47-
328, Newport Corporation, Irvine, CA) are placed along the AF and DR illumination 
light paths, and the parallel and perpendicular polarized AF/DR images can be 
acquired in tandem by rotating the analyzer positioned in front of the camera lens in 
the NIR AF/DR imaging system. To our knowledge, our integrated NIR AF and DR 
imaging system firstly combined polarization technique to acquire polarized AF and 
DR images from colonic tissues. 
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Fig. 3.1 Schematic diagram of the integrated NIR AF and NIR DR imaging 
system with polarization developed for tissue measurements: collimator (C); 
band pass filter (BP); neutral density filter (ND); dichroic mirror (DM); long 
pass filter (LP); polarizer (P); analyzer (A); lens (L). 
 
With this integrated NIR AF/DR imaging system combined with polarization 
technique, a set of six images can be acquired for colonic tissues in tandem, i.e., NIR 
AF image and the corresponding NIR DR image under three different excitation 
light polarization conditions (i.e., non-polarization; parallel and perpendicular 
polarization). The system fluorescence signal has been recorded as background 
images and subtracted automatically. The system acquires NIR AF images and DR 
images within the spectral bandwidth of 850-1100 nm, and each NIR AF image was 
acquired within 5 s with the 785 nm laser light irradiance of 0.15 W/cm2, which is 
less than the American National Standards Institute (ANSI) maximum permissible 
skin exposure limit set out for a 785-nm laser beam (1.63 W/cm2) [118], while each 
NIR DR image was acquired within 0.01 s with the tungsten light and the incident 
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optical power on sample surface is 0.002 W/cm2.  
 To explore the feasibility of our developed NIR AF imaging system, a 
chicken muscle-melanin sandwich model is developed to estimate the penetration 
depth of NIR AF imaging system. The sandwich model consists of chicken breast 
muscle tissue and melanin powder. Melanin, which is able to emit strong AF signal 
in the NIR region, is selected as an inclusion to embed in the chicken muscle 
sandwich. The bottom chicken muscle layer is 2 mm thick and the upper layers are 
several very thin chicken muscle layers with approximate thickness of 0.1 mm. Fig. 
3.2 (a) shows the AF image of solid melanin powder (~1 mm in diameter) on the 
center of the chicken muscle bottom layer without any upper layers. Under the 
excitation of 785 nm laser, the melanin powder emits strong NIR AF signal, which 
shows the bright point in the center of the images compared to surrounding chicken 
tissues. The Fig. 3.2 (b) is the intensity profile alone the line in the Fig. 3.2 (a).  We 
can roughly calculate the intensity ratio of melanin to chicken muscle by dividing 
the maximum intensity to the minimum one.  
 
Fig. 3.2 (a) NIR AF image of chicken muscle with melanin powder and (b) 





In order to measure the change of the AF intensity from the melanin with the 
incensement of thickness of the upper chicken muscle layer, the chicken muscle 
layers are placed on the top of chicken muscle base one by one. A series of NIR AF 
images are recorded after adding each chicken muscle layer and the ratio intensities 
of melanin to chicken muscle are calculated accordingly. The experiment repeats six 
times for the statistic analysis. Fig. 3.3 shows the mean NIR AF ratio of the melanin 
over the chicken muscle ± standard error (SE). The curve increases first till 
reaching the maximum at 0.2 mm and then decreases. The maximum value is not at 
the initial point and this could be attributed to the increasing of AF emission from 
melanin power. Due to the AF emission of first two chicken muscle layers, the 
melanin powder might be further excited and induce more AF emission. It also may 
be attributed to the nonuniformity of the excitation light distribution inside the tissue 
that may have a subsurface maximum. With the increment of the upper chicken 
muscle layer, the excitation light was significantly attenuated and the AF emission 
from melanin was also obscured. Thus, the ratio intensity of melanin to surrounding 
chicken muscle keeps decreasing with the increasement of thickness of upper 
chicken muscle layer. Based on the test of chicken muscle-melanin sandwich model, 
our NIR AF imaging system shows that our excitation light and resulting AF can 
penetrate up to 2.5 mm into chicken muscle tissues, approximately.  
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Fig. 3.3 The mean NIR AF intensity ratio of the melanin over the chicken muscle 
±1 standard error (SE) with the increasement of depth. 
 
To explore the fluorescence polarization technique for the detection and 
diagnosis of colon cancer, we acquired polarized NIR AF and DR images under 
every 20 degree for a total rotation of 360° and perpendicular polarized AF and DR 
images under 90° and 270°. For each image, a homogenous area (~2 x 2 mm2) on 
both normal and cancer tissue is selected respectively to estimate the average 
intensity. Fig. 3.4 is the polar diagrams to illustrate the change of NIR AF and DR 
signals as a function of polarization for a total rotation of 360°.  
 
Fig. 3.4 Polar diagrams displayed for a full sample rotation of every 20 degree 
for six paired colonic tissues, (a) NIR AF imaging, (b) NIR DR imaging. The 
error bars stand for the standard errors (SE).  
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The trend in intensity changes of AF and DR intensities are consistent in all 
six paired colonic tissues (normal vs. cancer). The maximum intensity is under the 
parallel-polarized condition (0° and 180°) while the minimum intensity is under the 
perpendicular-polarized condition (90° and 270°). The parallel-polarized images 
have the higher intensity than the perpendicular-polarized images for both NIR AF 
and DR imaging modes. This is because the parallel-polarized images mainly 
contain the information of structures on the surface or subsurface of the tissue while 
the perpendicular-polarized images predominantly contain information from deep 
areas of the tissue [116]. The observation of the intensity differences between 
parallel- and perpendicular polarization condition is in agreement with the literature 
[62]. As such, the polarized NIR AF imaging technique has the ability to selectively 
probe the AF light photons that arise from the subsurface or deep areas of tissue. We 
also calculated the polarization ratio value (ratio=(Ipar-Iper)/(Ipar+Iper)) for both normal 
and cancer tissues in NIR AF images to investigate the change of fluorescence 
polarization properties associated with the malignant transformation. The mean 
polarization ratio value of colonic cancer tissues is 0.34±0.04, while the mean 
polarization ratio value of normal tissue is 0.38±0.04.  The lower polarization ratio 
value of cancer tissues could be attributed to the more multiple light scatterings that 
occur in deeper regions of tissue due to the disorganized structures of tissue in 
colonic adenocarcinoma as compared to the normal tissue. Multiple scattering is 
caused by the high density of tissue scattering centers, originating from the random 
fluctuation of the local refractive index in the tissue microstructure, such as inside 
the cell and in the extra-cellular matrix. Due to hyperproliferation of cancerous cells, 
there might be an increase in the disorder of collagen network, such as the 
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breakdown of the crosslinkages between microfibrils and the deformation in the 
oriented collagen structure (collagen fibers are shortened and more disconnected). 
The organized fibrous structures such as collagen, which are the structural protein in 
the extracellular matrix of the colonic wall and the dominant fluorophore in the 
submucosa of colon tissues of colon tissues [115], are the main contribution to the 
retardence and diattenuation of the tissue due to its birefringent nature. Because of 
its hierarchical structure and fibril alignment, the optical anisotropy properties of 
collagen can be used to reflect the change of birefringent properties associated with 
structural or cellular metabolic progression in colonic precancer and cancer  [117]. 
Since the structural and functional properties of these fibers change as a result of 
tissue abnormalities, the colonic cancer tissues suffered stronger depolarization 
compared to the normal tissues. As such, the polarization measurements may also be 
used as a sensitive probe for assessing tissue status.    
3.2.2 Tissue preparation 
A total of 48 paired (i.e., normal vs. cancer) colonic tissue specimens (average size 
of ~4 x 4 x 2 mm3) were collected from 48 patients (20 men and 28 women with a 
mean age of 62) who underwent partial colectomy or surgical resections with 
clinically suspicious lesions or histopathologically proven malignancies in the colon. 
All patients preoperatively signed an informed consent permitting the investigative 
use of the tissue, and this study was approved by the Institutional Review Board 
(IRB) of the National Healthcare Group (NHG) of Singapore.  
Immediately after surgical resections, the tissue specimens are immersed in 
physiological saline solution and sent to the laboratory for NIR AF/DR imaging 
measurements. The paired tissue specimens from each patient were placed on a 
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standard glass slide (26×76×1.2 mm3) covered by aluminum foil which has very 
small fluorescence background. The cancer tissue was placed at the upper part of the 
slide while the normal one was placed at bottom part of the slide for NIR imaging 
measurements. After the NIR imaging acquisitions, the tissue specimens were fixed 
in 10% formalin solution and then submitted back to the hospital for 
histopathological examinations. The histopathogical examinations confirmed that 48 
tissue specimens were normal, and 48 tissue specimens were cancer (moderately 
differentiated adenocarcinoma).  
3.3  Results and Discussion 
3.3.1 NIR autofluorescence and reflectance diffuse imaging 
Using the integrated NIR AF/DR imaging system combined with the polarization 
technique, we have successfully acquired NIR AF/DR images of 48 paired colonic 
tissues under the three excitation light polarization conditions (i.e., non-polarization, 
parallel and perpendicular polarization). Fig. 3.5 shows the representative NIR DR 
images and AF images of one pair of colonic tissue (normal (9 ×6 mm2) vs. cancer 
(6 ×3.5 mm2) confirmed by histological examinations): (a) NIR DR image without 
polarization; (b) NIR DR image with parallel polarization, and (c) NIR DR image 
with perpendicular polarization; (d) NIR AF image without polarization; (e) NIR AF 
image with parallel polarization, and (f) NIR AF image with perpendicular 
polarization. Cancer tissue was located at the upper frame of images while the 
normal one was located at bottom frame of images. 
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Fig. 3.5 Representative NIR DR and AF images of colonic tissues acquired using 
tungsten halogen light illumination and 785 nm laser excitation under different 
polarization conditions: (a) DR with non-polarization, (b) DR with parallel 
polarization, (c) DR with perpendicular polarization, (d) AF with non-polarization, 
(e) AF with parallel polarization, (f) AF with perpendicular polarization. 
 
NIR DR images as shown in Fig. 3.5 (a-c) can not distinguish the difference 
between cancer and normal tissues by naked eyes. By contrast, the AF images under 
three different polarization conditions (Fig. 3.5 (d-f)) show that the cancer tissue, 
which is with the feature of lower intensity, can be easily distinguished from normal 
tissue. In order to further quantitative analysis the intensity difference between 
colonic normal and cancer tissue, we calculate the intensity ratio between the normal 
and cancer colonic tissue. As shown in Fig. 3.6, a homogenous area (~2 x 2 mm2) is 
selected to estimate the average intensity of both normal and cancer tissue 
respectively. Due to the size variation of colonic tissues from different patients, the 
size and the location of the homogenous area for calculating the average intensity 
are different individually. Fig. 3.6 shows the average intensity for both normal and 




normal tissue is 1.19 for the NIR DR image in Fig. 3.6 (a) and 2.7 for the NIR AF 
image in Fig. 3.6 (b). The experimental results demonstrate that 37 colon cancer 
tissues have lower AF intensity than the corresponding normal tissues. In other 
word, for 77.1% of paired colonic tissue, the intensity ratio of normal to cancer 
tissues is higher than 1. The mean value of the intensity ratios from all NIR AF 
imaging results is1.2 (p=3.5E-4). Whereas, the mean intensity ratio for all NIR DR 
images is 0.98 and not statistical significant for classification the cancer from normal 
colonic tissues.  
 
Fig. 3.6 The average AF intensity for the normal and cancer colonic tissues 
based on the selected region on (a) NIR DR image and (b) NIR AF images. 
 
Our integrated NIR AF imaging system successfully acquired NIR AF 
images of colonic normal and cancer tissues. Our results demonstrated that the colon 
cancer tissue can be identified from normal tissues with significant lower AF 
intensity in NIR AF images under different polarization conditions. This is because 
AF imaging takes advantage of the intrinsic fluorophores, which are associated with 
the structural matrix of tissues or involved in cellular metabolic processes, to assess 
both the structural and the biochemical progression of colon cancer. The differences 
of fluorescence intensity between normal and cancer tissue could be attributed to the 






the proliferation of neoplastic cells caused the thickening of mucosal tissue in cancer 
tissue [84, 115], which could significantly attenuate the excitation light penetration 
and also obscure the tissue AF emission from the tissue, resulting in an overall 
decrease of NIR AF intensity from cancer tissue as compared to normal colonic 
tissue. In addition, the changes in concentrations of endogenous fluorophores such 
as NADH, collagen, flavins, porphyrin, etc., in tissue associated with malignant 
transformation [84, 115, 119] may also attribute to the differences in the NIR AF 
emission between normal and cancer colonic tissue. But the origins of the specific 
endogenous fluorophores responsible for NIR AF emission in colonic tissue are still 
not well understood, which warrant further investigations, such as high-performance 
liquid chromatography (HPLC) can be used to identify, quantify and purify the 
individual components of the mixture actually. In Chapter 5, we developed the non-
negativity-constrained least squares minimization (NNCLSM) biochemical 
modeling to quantitative investigate the endogenous fluorophores which are 
responsible for the NIR AF differences between normal and cancer tissues.  
3.3.2 Polarization autofluorescence imaging 
In our NIR AF imaging system, we integrated the polarization technique into NIR 
AF imaging system to explore the diagnostic ability of polarization fluorescence 
imaging. Fig. 3.7 (a-c) shows the representative NIR AF images of the paired 
colonic specimens under the different polarization conditions in pseudo-color: (a) 
NIR AF image without polarization; (b) NIR AF image with parallel polarization, 
and (c) NIR AF image with perpendicular polarization. Fig. 3.7 (d) shows the 
intensity profiles along the lines as indicated on NIR AF images in Fig. 3.7(a-c), 
respectively, illustrating that the cancer tissue shows a relatively lower NIR AF 
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intensity than the normal tissue. Since the heterogeneous structure of tissue, the line 
was drawn to cross the homogenous area which located at the center of field of view. 
Then the ratio of average intensity of last 20 points to the first 20 points in intensity 
profile was calculated. For instance, NIR AF emission arising from cancer tissue 
reduces by 2.0-, 2.2-, and 2.4- fold, respectively, in intensity as compared to the 
normal tissue under the non-polarization, parallel and perpendicular polarization 
conditions. The contrast of NIR AF emission between normal and cancer colonic 
tissue has been enhanced in the parallel- and perpendicular polarization condition 
compared to the non-polarization condition.  
 
Fig. 3.7 Representative pseudocolor NIR AF images of colonic tissues 
acquired using 785 nm excitation under different polarization conditions: (a) 
non-polarization, (b) parallel polarization, and (c) perpendicular polarization. 
(d) Intensity profiles along the lines as indicated on the NIR AF images in (a-
c). Note that the AF intensity profiles under the parallel and perpendicular 
polarizations have been magnified by 4 times in Fig. 3.7(d) for better 
visualization. 
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To compare the diagnostic performance of NIR AF imaging under different 
polarization conditions, NIR AF intensities are as calculated from the homogenous 
area on the normal and cancer NIR AF images, respectively (Fig. 3.6). Fig. 3.8 (a-c) 
shows the pair-wise comparison of NIR AF intensities of all 48 paired (normal vs 
cancer) colonic tissues under the three polarization conditions (i.e., (a) non-
polarization, (b) parallel and (c) perpendicular polarization). NIR AF intensities of 
cancer tissue are significantly lower than those of normal tissue with the p-values of 
3.5E-4, 3.2E-8 and 5.8E-9, respectively, under the non-polarization, parallel and 
perpendicular polarization light excitation conditions (paired 2-sided Student’s t-test, 
n=48). Based on the intensity ratio of normal to cancer tissue (Inormal/Icancer), the 
diagnostic accuracies of 79.2% (38/48), 91.7% (44/48) and 93.8% (45/48), 
respectively, can be achieved by using the NIR AF imaging under the non-
polarization, parallel and perpendicular polarization light excitation. Hence, the 
polarized NIR AF imaging was able to enhance the contrast between normal and 
cancer colonic tissue with a higher diagnostic accuracy (of ~ 92-94%) compared to 
the non-polarized AF imaging (accuracy of ~79%).  
 
Fig. 3.8 Pair-wise comparison of NIR AF intensities of all 48 paired (normal vs. 
cancer) colonic tissues under the three different polarization conditions: (a) non-
polarization, (b) parallel polarization, and (c) perpendicular polarization. 
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To explore the possible reason that the polarized NIR AF imaging performs 
better than the non-polarized NIR AF imaging technique for detection of colon 
cancer, we have also studied NIR AF polarization properties of normal and cancer 
colonic tissue by calculating the polarization ratio values (Ratio=(Ipar-Iper)/(Ipar+Iper)) 
in NIR AF images (Fig. 3.9 (a)). It is observed that the polarization ratio values of 
cancer colonic tissue are in the range of 0.0001 to 0.01, while the polarization ratio 
values of normal tissue are much higher, ranging from 0.012 to 0.075 as shown in 
Fig. 3.9 (b). Similar to the polarized reflectance imaging [62], the parallel-polarized 
NIR AF imaging contains the information mainly from the surface or subsurface of 
the tissue, whereas the perpendicular-polarized NIR AF imaging reveals the 
information predominantly from deep areas of the tissue [62, 120]. A strong linear 
polarization of cancer tissue reflects that much more multiple light scatterings may 
occur in deeper regions of tissue due to the disorganized structures of tissue in 
colonic adenocarcinoma, resulting in a larger perpendicular polarized light 
component as compared to the normal tissue. As such, the polarized NIR AF 
imaging technique has the ability to selectively probe the AF light photons that arise 
from the subsurface or deep areas of tissue for improving cancer diagnosis and 
characterization. 
3.3.3 Ratio imaging of NIR DR/NIR AF 
The acquired Tissue NIR A F image not only depends on the tissue status (e.g., 
tissue surface structures, physiology or histopathology status, etc.), but also the 
measurement conditions (e.g., light excitation-tissue-collection configurations with 
respect to the tissue surface, illumination light power variation, etc.) [121]. To 
eliminate the geometrical effects on NIR AF measurements such as the variations of 
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the light source-tissue distance, the varying angles for the incident light and tissue 
fluorescence collections, and the irregularities of the tissue surface which are 
naturally encountered in practical tissue fluorescence imaging, we have also 
measured the NIR DR images from normal and cancer tissue serving as background 
image to normalize the NIR AF image for correcting the artifacts of NIR AF image 
non-uniformity. Fig. 3.10 (a-c) shows the NIR DR images of normal and cancer 
colonic tissue acquired under the three polarization conditions, which give no 
significance differences in NIR DR intensities between normal and cancer tissue (p-
values of 0.20, 0.28 and 0.17, respectively for the non-polarization, parallel and 
perpendicular polarization conditions, paired 2-sided Student’s t-test, n=48).  
 
 
Fig. 3.9 (a) The processed polarization ratio image ((Ipar-Iper)/(Ipar+Iper), 
where Ipar and Iper are the NIR AF intensities under the parallel and 
perpendicular polarization conditions) of normal and cancer tissue. (b) 
Polarized ratio values along the line across normal and cancer colonic tissue as 
indicated on the polarization ratio image in Fig.3.9 (a). 
 
When normalize the NIR DR images (Figs. 3.10 (a-c)) to the corresponding 
NIR AF images (Figs. 3.7 (a-c)), much enhanced differences in NIR ratio imaging 
between normal and cancer tissue can be observed clearly in Figs. 3.11 (a-c) (with 
the p-values of 5.0E-5, 2.5E-9 and 7.8E-10, respectively under the non-polarization, 
parallel and perpendicular polarization conditions (paired 2-sided Student’s t-test, 
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n=48)), and the NIR DR/NIR AF ratio values of cancer tissue can be ~2.8-fold larger 
than those of normal tissue (Fig. 3.8 (d)). The diagnostic accuracies of 83.3% 
(40/48), 93.8% (45/48) and 95.8% (46/48), respectively, can also be achieved by 
using the NIR DR/NIR AF ratio imaging under the non-polarization, parallel and 
perpendicular polarization conditions. 
 





















Fig. 3.10 NIR DR images of colonic tissues acquired using a broadband light 
source under different polarization illumination: (a) non-polarization, (b) 
parallel polarization, (c) perpendicular polarization, and (d) intensity profiles 
along the lines as indicated on the NIR DR images in (a-c). Note that the AF 
intensity profiles under the parallel and perpendicular polarizations have been 
magnified by 12 times in Fig. 3.7 d for better visualization. 
 
Therefore, with the ability of correcting the geometrical effects on NIR AF 
measurements, the NIR DR/NIR AF ratio imaging technique can further improve the 
diagnostic accuracy (of ~94 to 96%) for colon cancer detection, Since the white light 
source was shined on the tissue with an angle, we can observe the intensity gradient 
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from left to right (Fig. 3.10 and Fig. 3.11). With optimized the system, the non-
uniform illumination in DR image might be corrected if the white light could be 
coupled into the same light path as laser excitation. After integrating into 
conventional colonoscopy system, the NIR DR/NIR AF ratio imaging technique 
may have the potential for delineating the margins of tumors for surgical operation.  
 
 
Fig. 3.11 Ratio imaging of the NIR DR image to the NIR AF image under 
different polarization conditions: (a) non-polarization, (b) parallel polarization, 
(c) perpendicular polarization.  (d) Comparison of ratio intensity profiles along 
the lines as indicated on the ratio images in (a-c). Note that the ratio intensity 
profiles under parallel and perpendicular polarization have been magnified by 
3 times in Fig. 3.11 d for better visualization. 
 
3.4  Conclusion 
The diagnostic accuracies and p-values for classification normal and cancer tissue 
using different NIR imaging methods have been summarized in Table 1. We evaluate 
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the diagnostic ability of integrated NIR AF imaging system, in total nine imaging 
methods: NIR AF and the NIR DR images under non-, parallel- and perpendicular 
polarization conditions and corresponding ratio image NIR DR/NIR AF.  
Table 3.1 Comparison of diagnostic accuracy and p-value (paired 2-sided 
Student’s t-test)  of different NIR imaging modalities (i.e., NIR AF imaging 
and NIR DR image under non-, parallel- and perpendicular polarization, and 
the ratio imaging of NIR DR to NIR AF for detection of colon cancer.  
 
 





35.4%(17/48) 43.8%(21/48) 31.2%(15/48) NIR DR 
p=0.20 p=0.28 p=0.07 
77.1%(37/48) 91.6%(44/48) 93.8%(45/48) NIR AFI 
p=3.5E-4 p=5.8E-09 p=3.2E-08 
83.3% (40/48) 93.8% (45/48) 95.8% (46/48) Ratio imaging of NIR DR to NIR 
AF p=5.0E-4 p=1.3E-08 p=6.2E-08 
 
First, the NIR AF imaging takes the advantage of endogenous fluorophores 
and structure to investigate the differences of NIR AF emission between colonic 
normal and cancer tissue without using any chemical dyes. The distinctive difference 
of intensity in NIR AF images between normal and cancer tissue was employed to 
identify the cancer from normal colonic tissues. Second, the polarization 
fluorescence technique with the ability to select the fluorescence light that 
backscatters from the superficial tissues or deeper region of the tissue was developed 
to improve the diagnostic ability of NIR AF imaging. When the lesions invaded into 
different layer of the tissue, the polarization NIR AF imaging can yield images 
whose contrast is in the region of interest. As a result, the NIR AF imaging under 
polarized conditions gives a higher diagnostic accuracy (~92-94%) than the non-
polarized AF imaging (~79%), while the NIR DR imaging did not reach significance 
on statistical testing (P=0.20, 0.28 and 0.07). Finally, the NIR DR/NIR AF ratio 
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imaging further improves the diagnostic accuracy and achieved the best diagnostic 
accuracy (~96%) under perpendicular-polarization condition due to correction of the 
geometrical effects.  
In summary, we found that under the 785 nm laser excitation, NIR AF 
emission from colonic tissue can be detected and imaged by the sensitive NIR 
imaging system. Significant differences in AF intensity are observed between 
colonic normal and cancer tissue, indicating the feasibility of NIR AF imaging 
technique for detection of colon cancer. Then we combined the polarization 
technique with NIR AF imaging and the polarized NIR AF images yielded better 
diagnostic accuracy than the non-polarized images. Finally, the NIR DR/NIR AF 
ratio imaging under polarization condition further improves the colon cancer 
diagnosis and characterization. We anticipate that with further miniaturization of the 
current NIR excitation and imaging system coupled with an endoscope to realize the 
in vivo detection in different organs and it can be extended to the test any type of 
samples with contrast agents or without. The integrated NIR AF and NIR DR 
imaging with polarization excitation technique developed in this work may have the 
potential to be a clinically useful tool for in vivo diagnosis and detection of colon 
cancer during colonoscopic examination.  
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Chapter 4 Endoscopy Based Spectroscopy for in vivo 
Diagnosis of Colonic Polyps  
4.1  Introduction 
Available scientific data and considerable clinical experience have indicated that 
95% of colon cancers arise from benign adenomatous polyps [7]. In the past three 
decades, the concept of colon cancer development via benign neoplasms (e.g., 
adenomatous polyps) has progressively gained creditability. Fig. 4.1 shows a 
discontinuous process for the development of colon cancer, from normal mucosa, to 
an increased cellular proliferation, to early simple benign adenoma, to adenoma with 
advanced histological features, and finally to invasive carcinoma and metastases 
[122]. There is a close association between adenomas and carcinomas [123]. For 
instance, 30% of patients with colon cancer have at least one synchronous adenoma, 
and in patients with two or more synchronous cancers, 50-85% has synchronous 
adenoma [10]. Thus, the interruption of this adenoma-carcinoma sequence by 
finding and resecting precancerous polyps can effectively prevent colon cancer. 
Colonoscopy is the gold standard to detect and treat polyps in the colon. 
However, identification of adenomatous polyp can be difficult during routine 
colonoscopic examination. Since the conventional white light reflectance (WLR) 
colonoscopy heavily relied on the gross morphological tissue changes, investigations 
have demonstrated that 22% of polyps may be missed on the first colonoscopy [124]. 
Furthermore, subtle macroscopic differentiation between adenomatous and 
hyperplastic polyps may not be apparent under WLR endoscopic imaging, limiting 
diagnostic accuracy. Therefore, all polyps that were founded at colonoscopy are 
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routinely resected and send for histopathological examinations. But, the removal of 
hyperplastic polyps with no malignancy potential could incur additional time, costs, 
and risks. For diagnostic colonoscopy, serious complications of perforation and 
bleeding occur only in 0.1% to 0.2% of patients, whereas after applying 
polypectomy the incidence of serious complications of perforation or bleeding may 
be as high as 10% [105]. Moreover, there are increased time for colonoscopy 
procedure and additional cost of forceps and pathologies. Hence, it is of imperative 
clinic value to develop non-invasive and sensitive advanced optical diagnostic 
techniques for identification of adenomatous polyp during colonoscopy 
examinations. It would be a useful tool in the clinical to assist the endoscopists for 
the targeted biopsies to reduce unnecessary biopsy and associated risks and 
pathology costs.  
 


















In recent years, advanced optical spectroscopy and imaging techniques, 
which characterize tissue both at the microstructure and molecular level, have been 
investigated to complement the standard white light endoscopy for improving the 
non-invasive in vivo diagnosis of early cancer in the colon [125-127]. 
Chromoendoscopy takes advantage of chemical contrast  agents to identify small 
and flat polyps that might be missed on conventional WLR colonoscopy and ensure 
complete removal of neoplastic region during polypectomy [128]. Narrow band 
imaging (NBI), which uses of band-width filters to increase the blue spectrum 
intensity of the light, enhance the visualization of superficial capillaries. The 
neoplastic tissue can be identified from normal mucosa in NBI modality due to the 
prominent vascular network [129]. With the development of high-sensitivity near 
infrared (NIR) detectors and fiber-optic probes, NIR Raman spectroscopy has been 
applied for clinical differentiating adenomatous from hyperplastic polyps at the 
molecular level [130]. 
 In addition, laser-induced autofluorescence (AF) spectroscopy and imaging 
are capable of probing changes of tissue morphological structures and 
concentrations of endogenous fluorophores in the tissue. Alterations in the 
concentration and distribution of endogenous fluorophores, which are associated 
with neoplastic transformation, lead to differences in AF emission spectra among 
normal tissues, hyperplastic and adenomatous polyps. Therefore, the AF technique 
has shown the promise for distinguishing adenomatous polyps from normal tissue 
and hyperplastic polyps during colonoscopy [47, 105, 110, 131-134]. The 
commercial WavSTAT optical biopsy system with UV light excitation has been 
developed to provide accurate information to the gastroenterologist and assist in 
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classification of hyperplastic and adenomatous polyps [132]. But to date, few NIR 
AF applications have been developed for early cancer and cancer detection in the 
colon. In this work, we develop a NIR AF spectroscopy system to realize in vivo 
NIR AF measurements on the colonic polyp tissue under the guidance of wide-field 
endoscopic imaging. We employ the novel bifurcated flexible fiber-probe that can 
pass down the instrument channel of medical endoscopes for effective excitation 
light delivery and NIR AF and Raman signal collections [126]. The main aim of this 
study is to evaluate the diagnostic efficacy of the NIR AF spectroscopy for in vivo 
differentiation of colonic adenomatous polyps during colonoscopic examination.  
4.2  Experiments 
4.2.1 Integrated NIR AF spectroscopy system 
Fig. 4.2 shows the schematic diagram of the integrated fluorescence spectroscopy 
and wide-field endoscopic imaging system developed for in vivo tissue AF 
measurement at colonoscopy. The endoscopy-based fluorescence spectroscopy 
system consists of a spectrum-stabilized 785 nm diode laser (maximum output: 
300mW, B&W TEK Inc., Newark, DE); a scientific-grade spectrometer QE65000-
FL (FWHM=6nm, Ocean Optics, Dunedin, FL); and a specially designed 
endoscopic fiber probe (1.8mm in diameter, 2.5 m in length) for both laser light 
delivery and in vivo AF spectrum collection. The endoscopic fiber probe was 
composed of 32 collection fibers surrounding the central light delivery fiber (core 
diameter of 200 μm, N.A.=0.22) with two stages of optical filtering incorporated at 
the proximal and distal ends of the probe [126]. The distal end of the fiber probe is 
coated with two different types of filters; the central excitation fiber is coated with a 
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narrow bandpass filter (centered at 785 nm, FWHM= ±2.5nm), whereas the 
surrounding collection fibers are coated with edge long-pass filters (cut off at 800 
nm). The bandpass filter reduces most of the fused-silica noise generated in the 
excitation fiber of the fiber probe before the excitation beam hits the tissue, and the 
edge long-pass filters of the collection fibers reinforce the reflected excitation light 
to be blocked yet allow the scattered tissue signal to pass back to the detector. At the 
proximal ends of the fiber probe, the excitation and emission fibers were coupled 
into two separate in-line filter modules: one integrated with a narrow bandpass filter 
(LL01-785, Semrock, Inc.) for suppressing laser noise, fluorescence, and Raman 
emissions from the 200 μm core diameter fiber that connects the 785 nm laser to the 
in-line filter for tissue excitation, and one integrated with an edge long-pass filter 
(LP02-785RU, Semrock, Inc.) for further reduction of the laser light while 
permitting the scattered-tissue fluorescence signals to pass through toward the AF 
spectrometer. In the in-line filter modules, besides the filters, there are two lenses for 
effectively coupling the light into the fiber for laser excitation and AF signal 
collection.  
A personal computer controls the system using a custom-designed program 
that triggered data acquisition and background spectrum subtraction. The system 
acquired in vivo tissue AF spectra in the wavelength range of 810-1050 nm from 
colonic tissue within 1 second using 785 nm excitation power of 1 W/cm2, which is 
less than the ANSI maximum permissible skin exposure limit set out for a 785-nm 
laser beam [118]. The wide-field colonoscopy imaging system primarily comprises a 
300W dedicated short-arc xenon light source, a video colonoscopy (CF-Q160AL, 
Olympus), and a video system processor (CV-160, Olympus) for WLR imaging. 
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With this unique NIR AF endoscopic spectroscopy system, wide-field endoscopic 
images and the corresponding real-time in vivo AF spectra of colonic polyp imaged 
can be simultaneously acquired, displayed, and recorded in the video system and the 
PC, respectively.  
 
Fig. 4.2 Schematic diagram of the integrated autofluorescence spectroscopy and 
wide-field endoscopic imaging system for in vivo tissue AF measurement at 
colonoscopy.  
 
4.2.2 Patients and procedure 
This study was approved by the IRB of the NHG of Singapore. All patients 
preoperatively signed an informed consent permitting the in vivo AF endoscopic 
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spectroscopy measurements during colonoscopy. Fig. 4.3 (a-c) show the white-light 
reflectance (WLR) images of different types of colonic tissues during clinical 
colonoscopy. Under the guidance of wide-field WLR endoscopic imaging, the 1.8-
mm fiber probe was passed through the instrument channel of the colonoscope to 
gently contact on the tissue surface for acquiring in vivo tissue NIR AF spectra in 
real-time. Following the acquisitions of NIR AF spectra from suspicious colonic 
polyps, the surrounding normal colonic mucosal tissue (approximately 2 cm in 
distance away from the polyps) was also measured by NIR AF technique serving as 
a control. A total of 198 colonic tissue sites (116 normal tissue, 48 hyperplastic, and 
34 adenomatous polyps) were acquired from 96 patients (55 male and 41 female, 
with a median age of 50 years) undergoing colonoscopic screening. Immediately 
after NIR AF spectra acquisitions, all the tissue sites measured were biopsied or 
resected (e.g., polyps) and fixed in formalin for routine histopathologic examinations.  
 
Fig. 4.3 White-light reflectance (WLR) images of colonic tissues during clinical 
colonoscopy (a) normal, (b) polyp, and (c) cancer. 
 
4.2.3 Multivariate analysis 
AF spectroscopy can probe great wealth information of intrinsic fluorophores, such 
as collagen, elastin, and porphyrin. But the AF spectrum usually contains many 
overlapping bands and the data interpretation can not be easily based on simple 
(a) (b) (c)
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visual inspection for subtle change in tissues. Hence, different statistical techniques 
would be needed to analysis AF spectrum for tissue diagnosis and classification. The 
AF spectrum data usually consists of many different variables (i.e., intensity, 
spectral shape and wavelength) for different cases (i.e., normal tissue, hyperplastic 
polyp, and adenomatous polyp). Each of theses variables could be considered to 
represent a different dimension. Given n variables, each of the cases may be 
regarded to be located in a unique position in an n-dimensional hyperspace that is 
difficult to visualize. Therefore, various statistical algorithms have been explored to 
reduce this massive dimensional space to an interpretable  dimensional space [135]. 
Principal component analysis (PCA) 
PCA is a mathematical procedure that uses an orthogonal transformation to convert a 
set of observations variables, which are possibly correlated with each other, into a 
set of values of uncorrelated variables called principal components (PCs). PCA 
decomposes the spectroscopic data matrix S into scores T and loading P, according 
to the relation, 
PTS ⋅=                                                           (4.1) 
With this equation, PCA transforms a number of correlated variables into a number 
of uncorrelated variables (PCs) which describe the greatest variance of the spectral 
data. The number of PCs is less than or equal to the number of original variables. It 
is usually employed as a method for variable or data reduction by retaining the first 
few principal components. The first principal component accounts for as much of 
the variability in the data, and each succeeding component has the highest variance 
possible in turn. Each component is orthogonal to the preceding components. In 
addition, inspection of the plots generated by scores provides a mean to assess the 
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relationship between samples, since it helps to identify some clusters related to a 
certain feature and detect potential outliners.  
Linear discriminant analysis (LDA) 
LDA is used for pattern recognition and machine learning to find linear combination 
of the measurements variables that separate the objects from different classes as 
much as possible. The distance (e.g. euclidean distances) between groups and the 
compactness of each group are used to determine the separability of classes. Then 
LDA follows the rule that the ratio of the between-to-within variability of the 
transformed training data vectors (i.e. spectra) should be maximized. 
{ }withinbetweenMAX VarianceVarianceS /=                                (4.2) 
In other word, the aim of LDA is to find a discriminant function line that maximized 
the variance in the data between groups and minimizes the variance between 
members of the same group. LDA is closely related to PCA and both methods look 
for linear combinations of variables that best explain the data. LDA explicitly 
attempts to model the difference between the classes of data, while PCA does not 
take into account any difference in class.  
In this study, we applied PCA-LDA for multivariate analysis. The high 
dimension of florescence spectral space (each fluorescence spectrum ranging from 
810-1050 nm with a set of 325 intensities) will result in computational complexity 
and inefficiency in optimization and implementation of the LDA algorithms. As such, 
PCA was first performed on tissue fluorescence data set to reduce the dimension of 
fluorescence spectral space while retaining the most diagnostically significant 
information for tissue classification. To eliminate the influence of intersubject and/or 
intrasubject spectral variability on PCA, all spectra were standardized so that the 
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mean of the spectra was zero. Mean centering ensures that the PCs from an 
orthogonal basis [136]. Standardized AF data sets were assembled into data matrices 
with wavelength columns and individual case rows. The PCA was performed on the 
standardized spectral data matrices to generate PCs comprising a reduced number of 
orthogonal variables that accounted for most of the total variance in original spectra. 
Each loading vector is related to the original spectrum by a variable called PC score, 
which represents the weight of that particular component against the basis spectrum. 
PC scores reflect the differences between different classes. One-way analysis of 
variance (ANOVA) [135] was then used to identify the most diagnostically 
significant PCs (p<0.05) for separation of three different tissue classes. These 
significant PC scores were selected as input for the development of LDA algorithms 
for multiclass classification. LDA determines the discriminate function that 
maximizes the variances in the data between groups while minimizing the variances 
between members of the same group. The performance of the diagnostic algorithms 
rendered by the LDA models for correctly predicting the tissue groups was estimated 
in an unbiased manner using the leave-one-sample-out, cross-validation method on 
all model spectra. In this method, one sample (one spectrum) was held out from the 
data set, and the entire algorithm including PCA and LDA was redeveloped using 
the remaining tissue spectra. The algorithm was then used to classify the withheld 
spectrum. This process was repeated until all withheld spectra were classified. For 
the assessment of diagnostic sensitivity and specificity of NIR AF spectroscopy 
technique, histopathologic examination results serve as the gold standard. 
Multivariate statistical analysis was performed in the STATISTICA version 7 
(Statsoft Inc., Tulsa, Oklahoma, USA). 
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4.3 Results and Discussion 
We successfully employ the novel NIR AF spectroscopy system to acquire 198 in 
vivo NIR AF spectra under the guidance of colonoscopic WLR image from different 
types of colonic tissues, including normal (n=116), hyperplastic polyp (n=48), and 
adenomatous polyp (n=34) colonic tissues. Based on spectral characters among 
these different types of colonic tissues, we apply PCA-LDA to run three group 
classifications among normal, hyperplastic polyp, and adenomatous polyp for 
distinguishing the subtypes of colonic polyps. Good classification results 
demonstrate the diagnostic potential of integrated NIR AF spectroscopy to be a 
clinical complement to conventional WLR endoscopy for the rapid, non-invasive, in 
vivo differentiation of precancer (adenomatous polyps) and cancer in clinical 
colonoscopy procedures.  
Fig. 4.4 shows the in vivo mean NIR AF spectra ±1 standard errors (SE) of 
normal (n=116), hyperplastic (n=48), and adenomatous polyps (n=34) in the colon. 
On average, the NIR AF intensities of normal tissue in the entire spectral region of 
810-1050 nm are significantly higher than those of hyperplastic and adenomatous 
colonic polyps (p<0.001, one-way analysis of variance (ANOVA)); and NIR AF 
signals from adenomatous polyps are significantly lower than hyperplastic colonic 
polyps (p<0.001). The NIR AF spectral shapes from different types of colonic 
tissues show different decreasing trends with the increased wavelengths ranging 
from 810 to 1050 nm. In addition, the weak tissue Raman scatterings superimposed 
on the intense NIR AF spectra of different colonic tissues are also observed, which 
include the prominent Raman bands such as 875 cm-1 (v(C-C) hydroxyproline), 936 
cm-1 (ν (C-C) of proline and valine), 1078 cm-1 (ν(C-C) of phospholipids), 1265 cm-1 
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(amide III ν(CN) and δ(NH) of proteins), 1302 cm-1 (CH3CH2 twisting of proteins 
and nucleic acids), 1335 cm-1 (CH3CH2 wagging of proteins and nucleic acids), 
1445 cm-1 (δ(CH2) of proteins an lipids), 1665 cm-1 (amide I v(C=O) of proteins) 
and 1745 cm-1 (v(C=O) of phospholipids), as well as the strong Raman peaks 
appearing at 2885 cm-1 (CH2 stretching of lipids) and 2940 cm-1 (CH3 stretching of 
proteins) [115, 137-151].  
 
Fig. 4.4 In vivo mean NIR AF spectra ±1 SE of normal (n=116), hyperplastic 
(n=48) and adenomatous polyps (n=34) colonic tissue. Note that in vivo NIR AF 
spectra of normal colonic tissue are vertically shifted for better visualization. The 
shaded areas in tissue AF spectra stand for the respective standard error.  
 
The spectral shape differences from 810 to 1050 nm are apparent for NIR AF 
spectra among the three different colonic tissue types (i.e., normal, hyperplastic and 
adenomatous polyps). The ratios of NIR AF spectra of normal to hyperplastic and 
adenomatous polyps are not flat horizontal lines but increase from 810 to 1005 nm 
and then decrease until close to 1015 nm and finally increase again till 1050 nm 
(data not shown). Although no distinctive differences in Raman peak positions are 
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observed between normal, hyperplastic and adenomatous polyps tissues, by 
normalizing the colonic tissue Raman spectra [143], changes in Raman spectral 
lineshapes and relative intensities between normal and colonic polyps tissues are 
also revealed (data not shown). Hence, the NIR AF differences in both the spectral 
intensities and lineshapes of different colonic tissues observed in this study confirm 
the potential role of NIR AF spectroscopy technique for in vivo diagnosis of 
hyperplastic and adenomatous polyps in the colon.  
In attempt to determine the most diagnostically significant AF features for 
identifying adenomatous polyp tissue from normal tissue and hyperplastic polyp 
colonic tissue, we have employed the multivariate statistical technique (PCA) 
together with the one-way ANOVA test to identify the significant principal 
components (PCs) of in vivo NIR AF spectra for differentiation among normal, 
hyperplastic and adenomatous colonic polyps. The first eight PCs (PC1- PC8) scores 
(Fig. 4.5) accounting for ~99% of the total variance are found to contain the 
diagnostically significant NIR AF/Raman features (p<0.05) for classification of 
different colonic tissues types. One notes that the first PC accounts for the largest 
variance (~80.50% of the total variance), and the successive PCs contribute 
progressively smaller variances (PC2~10.08%, PC3~4.05%, PC4~2.52%, 
PC5~0.79%, PC6~0.42%, PC7~0.12%, and PC8~0.09%). Some PC features, such as 
spectral line shapes, troughs, and peaks, are similar to tissue NIR AF spectra and 
Raman spectra of colonic tissues (Fig. 4.4).   
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Fig. 4.5 The first eight significant principal components (PCs) (PC1~80.50%, 
PC2~10.08 %, PC3~4.05%, PC4~2.52%, PC5~0.79%, PC6~0.42%, PC7~0.12%, 
and PC8~0.09%) accounting for ~99% of the total variance calculated from in vivo 
NIR AF spectra. 
 
Fig. 4.6 shows the relationship between the diagnostically significant 
difference colonic tissue types. Fisher’s least significant difference tests showed the 
different PC scores were largely associated with different degrees of diagnostic 
utility for classification of different colonic tissue types (normal tissue, hyperplastic 
polyp and adenomatous polyp). For instance, PC1 can be sued for differentiating 
hyperplastic poly from normal tissue and adenomatous polyp; PC2 is optimal in 
discriminating normal tissue from hyperplastic and adenomatous polyp; PC3 and 
PC7 can be used to distinguish adenomatous polyp from hyperplastic polyp and 
normal tissue; PC4 and PC6 can be used to separate adenomatous polyp from 
normal tissue; PC5 show efficacy in classification of the three different colonic 
tissue types; PC8 can be used to separate hyperplastic polyp from normal tissue. 
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Fig. 4.6 Box charts of the eight significant principal component (PC) scores for the 
three colonic types (normal, hyperplastic polyp and adenomatous polyp): a PC1, b 
PC2, c PC3, d PC4, e PC5, f PC6, g PC7, and h PC8. The line within each notch box 
represents the median, and the lower and upper boundaries of the box indicate first 
(25 percent percentile) and third (75 percent percentile) quartiles respectively. Error 
bars (whiskers) represent the 1.5-fold interquartile range. *P< 0.05 (pairwise 




All the significant eight PCs are then fed into the LDA model together with 
leave-one tissue-out cross validation to develop effective diagnostic algorithms for 
classification of different colonic tissues. Fig. 4.7 shows the ternary plot of depicting 
probabilistic outcomes in association with NIR AF data from normal, hyperplastic, 
and adenomatous polyp tissues, respectively. The final diagnostic category of each 
NIR AF data is determined by the nearest proximity of data to the diagnostic 
category related to the vertex of the ternary plot. The vertices in Fig. 4.7 represent 
the 100% posterior probabilities belonging to normal, hyperplastic, and 
adenomatous polyps, respectively. Table 1 summarized the classification results of in 
vivo NIR AF spectra of different colonic tissues. The diagnostic sensitivities of 
83.6%, 77.1%, and 88.2%; specificities of 96.3%, 88.0%, and 92.1%; and accuracies 
of 88.9%, 85.4%, and 91.4%, respectively, are achieved using NIR AF spectroscopy 
for differentiation of normal, hyperplastic, and adenomatous colonic polyps. 
In this study, we investigate the in vivo NIR AF spectral properties of normal, 
hyperplastic, and adenomatous colonic polyps, and explore the potential of 
translating the wealthy information of tissue morphological structure and 
endogenous fluorophores within the NIR AF spectra into clinically diagnostic 
algorithms to realize in vivo endoscopic identification of hyperplastic and 
adenomatous polyps in the colon. To understand and interpret the spectral 
differences among normal, hyperplastic, and adenomatous colonic polyps, it is 
important to know the origins of NIR AF spectral signals in the colonic tissues. To 
date, there are only a very limited number of tissue AF studies conducted at longer 
red to NIR wavelengths, which were mostly centered for centered for examining 
tissue porphyrin-related florescence [101]. Porphyrins, which  exhibits significant 
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absorption in the red/NIR spectral region accompanied by emission in the far-red 
and NIR regions [152], has been assumed as the major endogenous fluorophores 
responsible for NIR AF emission in tissues and the accumulation of porphyrins in 
various types of cancer has been discovered [153]. One should notice the possibility 
that NIR AF may also arise from biomolecules other than porphyrins, which may 
also be unevenly distributed between normal and tumor tissue and thus the origins of 
the specific endogenous fluorophores responsible for NIR AF emission in colonic 
tissue are still not well understood. 
 
Fig. 4.7 Two-dimensional ternary plot of the posterior probability belonging to 
normal tissue, hyperplastic and adenomatous polyp, illustrating the good 
clusterings of the three different colonic tissue types achieved by PCA-LDA 






Table 4.1 Classification results of in vivo NIR AF spectra prediction for the three 
colonic tissue groups using PCA-LDA algorithms, together with the leave-one 
tissue site-out, cross validation method.  
 Autofluorescence prediction 
 Normal Hyperplastic polyp Adenomatous polyp Total 
Normal 97 14 5 116 
Hyperplastic 
polyp 
3 37 8 48 
Adenomatous 
polyp 
0 4 30 34 
Sensitivity (%) 83.6 77.1 88.2  
Specificity (%) 96.3 88 92.1  
Accuracy (%) 88.9 85.4 91.4  
 
To investigate the endogenous fluorophores which are also responsible for 
the differences of NIR AF emission among normal, hyperplastic and adenomatous 
colonic polyps, we have developed the non-negativity-constrained least squares 
minimization (NNCLSM) biochemical modeling to analysis the biochemical 
compositions of colonic tissue [154]. Our modeling results showing the increased 
contents of hematoporphyrin for the adenomatous polyps than hyperplastic polyps 
and normal tissue were in agreement with previous reports [101]. The modeling 
results also shows that, adenomatous colonic polyps show lower contents belonging 
to collagen I, flavin adenine dinucleotide (FAD), β-nicotinamide adenine 
dinucleotide (β-NADH), L-tryptophan, and pyridoxal 5’-phosphate, while higher fit 
coefficients belonging to 4-pyridoxic acid, and water as compared to normal and 
hyperplastic polyps. We believe that the significant differences in both the spectral 
intensities and lineshapes of different colonic tissues (Fig. 4.4) could be attributed to 
the changes in concentrations and distribution changes of these endogenous 
fluorophores associated with structural or cellular metabolic progression in colonic 
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precancer and cancer. In addition, the alterations of tissue optical properties 
associated with adeno-carcinomatous progression could also cause the decreased 
NIR AF intensity of hyperplastic and adenomatous polyps compared to normal 
colonic tissue [84]. Due to cellular hyperproliferation, the thickening of the mucosa 
layer could significantly attenuate the excitation light penetration and also obscure 
the tissue AF emission from submucosa layer in the polyp tissue compared to 
normal colonic tissue [115]. For the adenomatous polyp, the growth of these crypt 
cells displace the lamina propria and further reduce the collagen AF emission from 
the lamina propria [84]. However there are many complicated biochemical 
processed to influence progression of polyp to colonic cancer associated with the 
structural matrix or cellular metabolism, resulting the differences of AF emission 
from different types of colonic tissues, and thus further investigation is required. 
The good discriminant results obtained by employing the NIR AF spectra, 
which contain both NIR AF and Raman signatures, might be explained as follows. 
Tissue comprises various fluorophores (e.g., collagen, elastin, proteins, lipids, etc.) 
and each fluorophore has a different autofluorescence spectral pattern at specific 
excitation wavelengths [114]. In general, fluorescence spectroscopy is very sensitive 
to tissue biochemical and morphological changes but it is inaccurate in determining 
the types of specific changes occurring in tissue due to its very broad spectral lines 
shapes. In contrast, Raman spectroscopy gives fingerprinting-type narrow spectral 
features that are very specific fro different types of tissue biochemical changes. For 
instance, the prominent Raman signals at 1302 cm -1, 1445cm-1, and 2885 cm-1 with 
its own sharp spectral features can be attributed to proteins, lipids, and DNA that are 
involved in the metabolic activities [137, 144, 146, 155]. During development and 
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progression of colonic polyp to cancer, epithelial cells undergo transformations that 
result in increased metabolic activity (e.g., increased mitotic activities that include 
enzymes, hormones, etc.) and the increased hyperchromatism and the nucleic acids-
to-cytoplasm ratio of dysplastic cells [127, 130]. As such, the inherently weak 
Raman signals from tissues, which can probe biomolecular structures and 
conformations of tissue, have be applied for the early detection of precancer and 
cancer in different organs [143, 146, 156]. The raw spectral data containing both 
Raman and AF signatures offers an opportunity to examine both the biomolecular 
structure and composition of the tissue (Raman) as well as the endogenous 
fluorophores and morphological structures in tissue (AF), thereby providing more 
diagnostic information for tissue diagnosis and characterization. Therefore, Raman 
and AF are complementary optical techniques that provide different information 
about tissue under investigation. The combination of NIR AF spectra with the 
Raman signals using PCA-LDA can be a powerful tool for elucidating the 
biochemical structure and composition of tissue and thus may provide better 
diagnostic capability for tissue diagnosis. 
 
4.4  Conclusions  
We have acquired for first time in vivo NIR AF spectra from colonic tissues at 785 
nm excitation during clinical colonoscopic examinations. We extend the previous 
UV/VIS AF work [105, 132, 134] to the NIR domain for colonic adenomatous polyp 
differentiation and characterization. Significant differences in both spectral shapes 
and intensities of in vivo NIR AF spectra among normal, hyperplastic, and 
adenomatous colonic polyps are observed. As biological tissue is very complex, 
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there are many factors related to morphological and biomolecular changes taking 
part in a myriad of biochemical processes to influence disease concurrently. 
Multivariate statistical techniques (e.g., PCA-LDA) can fully use the entire tissue 
spectra and elucidate diagnostic information for classification of multiple 
pathologies for cancer diagnosis and detection [127, 130, 136, 156]. In this study, 
Good classification between different colonic tissue types can be achieved using 
PCA-LDA modeling, suggesting the clinical potential of NIR AF technique for the 
rapid in vivo diagnosis and detection of colonic precancer and cancer during clinical 
colonoscopic procedures. 
 78
Chapter 5 Study of Origin of Endogenous 
Fluorophores for NIR Autofluorescence 
5.1  Introduction of Endogenous Fluorophores 
The application of autofluorescence (AF) imaging and spectroscopy has been well 
investigated for in vivo and ex vivo diagnosis of cancers in different organs for 
several decades [85-89]. AF technique, which takes advantage of endogenous 
fluorophores, has been explored to improve the accuracy for detection and diagnosis 
of precancer and cancer in the colon [46, 80, 92, 96, 106-110]. Chapter 3 and 4 have 
demonstrated the potential of NIR AF imaging and spectroscopy to complement 
conventional endoscopy to provide in vivo, real-time, and non-invasive detection 
and diagnosis of precancer and cancer in the colon. However, the biological basis for 
the differences of AF emission between normal and diseased tissue is still not well 
understood. Hence, a better understanding of the origin of tissue AF (i.e., 
endogenous fluorophores) is needed for fully exploiting the potential of AF-based 
tissue diagnosis and better understanding its limitation [81].  
In general, the biochemical species are structural and metabolic. When cells 
in various disease states, they undergo different rates of metabolism or have different 
structures. Consequently, alterations occur in the concentration of fluorophores, their 
spatial distribution, local microenvironment surrounding the fluorophores, and the 
particular tissue architecture. These alterations result in distinct differences of AF 
emission for the diseased tissues compared to the normal ones. Therefore, tissue AF 
can provide a significant amount of information of the endogenous fluorophores, 
which are responsible for the tissue’s morphological structure or involved in the 
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metabolic and functional processes of cells. Here, we summarize some known 
endogenous fluorophores and their fluorescence properties in biological tissues. 
Amino acids 
Proteins contain three aromatic amino acids residues (tryptophan, tyrosine and 
phenylalanine) that may contribute to their intrinsic fluorescence [157]. These three 
amino acids have different excitation and emission spectra and different quantum 
efficiencies. Tryptophan exhibits higher quantum efficiency than those of tyrosine 
and phenylalanine. It has an maximum emission at wavelength (345 nm), which is 
longer than those of tyrosine (303 nm) and phenylalanine (282 nm) with excited 
below 280 nm [158]. The composition of amino acid can influence the fluorescence 
emission of proteins. Typically, tryptophan accounts for the majority of protein 
fluorescence and its emission is sensitivity to the polarity of the environment.  
Structural proteins 
Structural proteins show maximum absorption at 240-280 nm and emission at 280-
350 nm regions, respectively. Collagen and elastin account for the connective tissue 
and exhibit a strong fluorescence emission shifted to longer wavelengths. Collagen 
is the major extracellular matrix component and there are at least 11 types of 
collagen according to the different composition of the monomeric chains and the 
degree of polymerization. The fluorescence of collagen has an excitation maximum 
at 330-340 nm and emission maximum at 400-410 nm. Elastin is the major 
component of the elastic fibers in most connective tissue along with collagen. The 
fluorescence of elastin has an excitation maximum at 350 nm and an emission 
maximum at 420 nm.  
Collagen and elastin are important in the diagnostic application of AF since 
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they are highly fluorescent biochemicals. Their contributions to the overall AF 
depend on the histological organization of the tissue. In the submucosa layer, 
collagen and elastin are the most abundant fluorophores and they have been used for 
diagnosis of neoplasia of multilayered epithelial tissue, such as cervical, gastric, and 
colonic tissues [159]. For instance, in normal colon tissues, the detected AF is 
dominated by the submucosal tissue [115]. However, the invasiveness of tumor cells 
induces thickening of mucosal and replace the most fluorescent component lamina 
propria by lesser fluorescent neoplastic crypt cells [84]. Thus, the colonic cancer 
tissues can be identified from normal tissues based on the reduced fluorescence 
signals [84, 160-161]. 
Pyridine nucleotides and flavins  
The pyrindine nucleotides and flavins have an important role in cellular energy 
metabolism [162]. They are mainly responsible for the fluorescence emission rising 
form the cytoplasm of single cells. Their cytoplasmic localization is related to their 
participation to most part of metabolic reactions, which lead to energy production or 
anabolic and catabolic functions in the cell [162]. Nicotinamide adenine dinucleotide 
(NADH) is mainly involved in reactions leading to energy production, while 
nicotinamide adenine dinucleotide (NADPH) is the major electron acceptor for 
reductive biosyntheses. NADH absorbs at about 340 nm and fluoresces in the 420-
490 nm regions and its fluorescence properties are associated with the nicotinamide 
group in the reduced state. Flavin adenine dinucleotide (FAD) is the other major 
electron acceptor. The oxidized form, FAD is fluorescent with the absorption 
maximum at 445 nm and the emission maximum at 525 nm. Several investigators 
have reported that when excited in the near-ultraviolet (near-UV) region, the reduced 
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AF near 500 nm in tumor may due to the decrease in the oxidized forms of flavins 
and the relative amount of NADH in malignant tissues compared to normal 
surrounding tissues [87, 163].  
Porphyrins 
Porphyrins are a ubiquitous class of naturally occurring molecules that involved in 
various biological processes, such as transport of oxygen, catalysis and pigmentation. 
At early 1924, red fluorescence of necrotic tumors was noted in the study of rat 
sarcoms [164]. In 1960, porphyrins, which are with an excitation maximum near 410 
nm and emission maxima at 630 and 690 nm, are confirmed as the specificity of the 
red fluorescence [165]. A pathological accumulation of porphyrins can be attributed 
to some specific enzyme defects in the biosynthesis of heme. At present, neoplastic 
lesion can be diagnosed by administering the precursor 5-aminolevulinic acid (ALA) 
to monitor the change of amount of protoporphyrin XI [166]. In addition, porphyrin 
derivatives have been explored for the photodynamic therapy of tumors due to their 
ability to activate photodynamic processes and lead to the production of species 
[167]. 
Vitamins 
Only a few of vitamins attract attention for the study of fluorophores due to their 
especially spectral properties and functional metabolic engagement in tissue, such as 
FAD precursor vitamin B2 (riboflavin), Vitamins B6 and A. Vitamins B6 (pyridoxine) 
and its metabolites exhibit an appreciable AF signal. It participates in numerous 
reactions, such as metabolism of amino acids, and lipids [109]. Pyridoxal 5’-
phosphate (PLP), which is the main circulation form of vitamin B6, exhibits an 
excitation maximum ranging from 330-390 nm and an emission varying from 400-
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500 nm. It is important in one-carbon metabolism and is critical for DNA synthesis 
and methylation, both of which are potential involved in colorectal carcinogenesis 
[168].  
Based on the understanding of these endogenous fluorophores, AF imaging 
and spectroscopy have been applied for diagnosis of precancerous (adenomatous 
polyp) and cancer with high-detection sensitivities, especially in the UV or short 
visible (VIS) regions in the past two decades [47, 110, 131-132, 134]. However, NIR 
AF clinical applications have been limited not only by the difficulty in capturing 
inherently weak tissue NIR AF signals, but also by relatively few studies of 
endogenous fluorophores in the NIR region. In this chapter, we develop a 
biochemical modeling (i.e., non-negativity constrained least squares minimization 
(NNCLSM)) to study the biochemical constituents of different types of colonic 
tissues in the NIR region.  
5.2  Experiments  
5.2.1 The partial least square model 
Partial least-squares modeling is a powerful new multivariate statistical tool that has 
been successfully applied to the quantitative analysis near-infrared data [169]. In this 
study, we develop a semi-quantitative biochemical analysis algorithm based on a 
prior biochemical knowledge using a linear combination (i.e., NNCLSM) of 
representative basis reference spectra acquired from biochemicals in colonic tissues 
[170].  This can be used to provide a ‘best fit’ of the spectral components or basis 
spectra found with in the measured spectrum. The contribution of each basis 
spectrum to the in vivo colonic AF spectra was calculated by normalizing the 
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NNCLSM fit coefficients. The differences between the original AF spectra and the 
least-square fitting spectra presumably arise from the contribution of other 





−⋅= , where .0≥c                                     (5.1) 
Where c is the matrix of concentrations or contribution coefficients to be predicted, 
S is the matrix of spectral components of biochemicals, and d is the measured 
spectrum of different types of colonic tissues. This can be used to provide a ‘best fit’ 
of the spectral components or basis spectra found within the measured spectrum by 
minimizing the difference E between Sc ⋅ and d. The contribution of each basis 
spectrum to the in vivo colonic AF spectra was calculated by normalizing the 
NNCLSM fit coefficients. The residual variations between the original AF spectra 
and the least-square fitting spectra presumably mainly arise from the contributions 
of other molecules that are not included in the modeling. The one advantage of 
NNCLSM modeling is that it is applicable even when there other molecules that 
contribute to the in vivo colonic spectra than those included in the model [170]. 
5.2.2 Tissue specimens spectra 
Under the guidance of wide-field endoscopic WLR images, in vivo NIR AF spectra 
of colonic tissue sites were acquired from 100 patients (57 male and 43 female, with 
a median age of 51 years) who underwent colonoscopy screening. In total 263 in 
vivo NIR AF spectra were used to run the biochemical fitting model, in which 116 
spectra were from normal, 48 spectra were from hyperplastic polyp, 34 spectra were 
from precancer (adenomatous polyps), and 65 spectra were from colonic cancer 
tissues.  
 For the ex vivo colonic tissues, a total of 17 paired (i.e., normal vs. cancer) 
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colonic tissue specimens were collected from 17 patients (6 men and 11 women with 
a mean age of 58) who underwent partial colectomy or surgical resections with 
clinically suspicious lesions or histopathologically proven malignancies in the colon. 
All patients preoperatively signed an informed consent permitting the investigative 
use of the tissue. In total, 100 NIR AF spectra of resected colonic tissues were 
included for biochemical analysis, in which 68 spectra were from normal and 32 
were from colon cancer tissue.  
5.2.3 Basis reference biochemicals 
Nine basis reference AF spectra are obtained from the following biochemicals 
(Sigma-Aldrich, St. Louis, MO, USA) for colonic tissue biochemical fitting, i.e., 
Collagen I (C9879), Elastin (E1625), FAD (F6625), β-NADH (N4505), L-
tryphophan (T0254), Hematoporphyrin (H5518), 4-pyridoxic acid (P9630) and 
pyridoxal 5’-phosphate (82870). They represent the main biochemical components 
with in colonic cells and tissues [109, 159-160, 168, 171-174]. For instance, 
collagen I and elastin are representative of structural proteins in the extracellular 
matrix of the colonic wall [159]; 4-pyridoxic acid and pyridoxal 5’-phosphate 
represents the active form of vitamin B6 [175];  β-NADH is the co-enzymes in 
oxidation-reduction reactions [176]; L-tryptophan represents amino acid that body 
use to synthesize the protein [177]; Hematoporphyrin is an endogenous porphyrin 
formed by the hydrolysis of hemoglobin [167]; FAD is the  enzymes typically 
involve in metabolism [110]. Besides these biochemicals, the deionized water was 
also included for spectral modeling since water is one of the main components in the 
body and helps conversion of mechanical energy into chemical energy for cell 
processes [178].  
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The spectra of these nine biochemicals were measured directly on their 
original form without any further purification or preprocessing using the 
instrumentation previously described in the Chapter 4 for the in vivo measurements 
of colonic polyps. For the powder biochemicals, they will be placed in the center of 
the glass slide covered by the aluminum foil. The diameter of the powder is big 
enough to cover the laser spot and the depth is thick enough for preventing the 
reflectance from aluminum foil. For the water, it is sorted in the cap covered by the 
aluminum foil and the depth of the water is around 3 cm. The water spectrum 
acquired is without NIR AF background signal from aluminum foil. 
5.3  Results and Discussion 
5.3.1 In vivo colonic tissues   
Fig. 5.1 shows the in vivo mean autofluorescence spectra ±1 standard error (SE) of 
normal (n=116), hyperplastic polyp (n=48), adenomatous polyp (n=34), and cancer 
(n=65) colonic tissues. All the spectra were acquired under the guidance of WLR 
endoscopic images during clinical colonoscopic examination. The significant 
differences of AF intensity were observed among different types of colonic tissue. 
Cancer tissues show much lower intensity compared to other three types of colonic 
tissues (normal, hyperplastic polyp, and adenomatous polyp). The adenomatous 
polyps with lower AF intensity can be distinguished from hyperplastic polyps and 
normal tissue as shown in Fig. 5.1. The intensity differences between hyperplastic 
polyp and normal tissue are not obvious. This is because hyperplastic polyp is still a 
type of noncancerous growth in the colon. These differences of fluorescence 
intensity among normal, hyperplastic polyp, adenomatous polyp, and cancer tissue 
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could be attributed to the changes of tissue optical properties in the colon as we 
discussed in Chapter 4. Due to hyperproliferation, the thickening of mucosa layer 
significant attenuates of the excitation light penetration and also obscures the tissue 
AF emission from the polyp tissue and cancer tissues [84, 115].  
















 Normal (n= 116)
 Hyperplastic poly (n= 48)
 Adenomatous polyp (n= 34)
 Cancer (n= 65)
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Fig. 5.1 In vivo mean NIR AF spectra ±1 standard error (SE) of normal (n=116), 
hyperplastic polyps (n=48), adenomatous polyps (n=34), and cancer (n=65) colonic 
tissue. The shaded areas in tissue AF spectra stand for the respective standard error. 
Note that in vivo NIR AF spectra of normal colonic tissue are vertically shifted for 
better visualization.  
 
In addition, the changes in concentrations and distribution of endogenous 
fluorophores may also attribute to the differences in the NIR AF emission among 
different types of colonic tissues. However, the changes of endogenous fluorophores 
are complex and few studies have been done in the NIR region. Porphyrins are 
assumed as the major fluorophores to be responsible for the NIF AF in the tissues. 
We extend the previous study of endogenous fluorophores in the UV/VIS region 
[109] to NIR region and further explored the optical properties of endogenous 
fluorophores in the NIR region. By utilizing the NNCLSM model, the concentration 
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for endogenous fluorophores was calculated among different types of colonic tissues. 
The differences of concentration for different fluorophores among normal, 
hyperplastic polyp, adenomatous polyp, and cancer colonic tissues were investigated. 
To investigate the origin of tissue biochemicals, which are responsible for the 
differences among normal, hyperplastic polyp, adenomatous polyp, and cancer 
colonic tissue, we explore NNCSLM algorithm to reconstruct tissue AF spectrum of 
each type by a database of nine basis reference spectra. These nine biochemicals are 
the major tissue biochemical constituents present in the colon, including: collagen 
type I, β-NADH, FAD, L-tryptophan, Elastin, hematoporphyrin, 4-pyridoxic acid, 
pyridoxal 5’-phosphate and water. We measure the NIR spectra from these nine 
biochemicals with our integrated NIR AF spectroscopy system. Fig. 5.2 shows the 
NIR AF spectra of nine chemicals that are measured without any further processing. 
Because of special design of fiber probe, our integrated NIR AF spectroscopy can 
acquire both the AF and Raman signals. The prominent Raman peaks can be 
observed in our biochemical spectra, such as β-NADH, FAD, L-tryptophan. The 
spectra acquired from colonic tissue are also composite NIR AF and Raman spectra 





Fig. 5.2 The nine basis reference AF spectra form collagen I, elastin, β-NADH, 
FAD, L-tryptophan, hematoporphyrin, 4-pyridoxic acid, pyridoxal 5’-phosphate 
and water are used for biochemical modeling of the colonic tissue. 
 
Based on the equation 5.1, NIR AF spectra measured from nine biochemicals 
are used as basis reference to fit 263 colonic tissues spectra individually. Fig. 5.3 
shows the representative comparison of the reconstructed spectra to the in vivo AF 
spectra measured from normal, hyperplastic polyp, adenomatous polyp, and cancer 
colonic tissue, respectively. It is evident that acceptable fit-residuals between the 
reconstructed AF spectra and the measured AF spectra can be achieved (residual 
variations: (a) normal: ±2.8E-4; (b) hyperplastic polyp: ±3.07E-4 (c) adenomatous 
polyp: ±2.9E-4; (d) cancer: ±2.18E-4), substantiating the implications of the chosen 
biochemicals in colonic tissue. The fit coefficients which are the relative 
concentration for nine reference biochemicals can be obtained for different types of 
colonic tissues.  
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Fig. 5.3 Comparison of in vivo colonic AF spectra measured with the reconstructed 
tissue AF spectra through the employment of the nine basis reference AF spectra: 
(a) normal, (b) hyperplastic polyp, (c) adenomatous polyp, and (d) cancer colonic 
tissues. Residuals (measured spectrum minus reconstructed spectrum) are also 
shown in each plot. 
 
Fig. 5.4 shows the mean fit coefficients for each of the reference 
biochemicals in normal, hyperplastic polyp, adenomatous polyp, and cancer tissue. 
One-way ANOVA [135] illustrates that the adenomatous polyp and cancer colonic 
tissues are associated with lower fit coefficient belonging to collagen (p=7.33E-4), 
β-NADH (p=5.44E-15), FAD (p=7.88E-6), L-tryptophan (p=5.207E-14), elastin 
(p=1.62E-4), pyridoxal 5’-phosphate (p=4.9E-2), while higher fit coefficients 
belonging to hematophophrin (p=4.81E-4), 4-pyridoxic acid (p=3.9E-4) and water  
(p=4.46E-13), as compared to the normal and hyperplastic polyp tissues. Overall, 
there are significant changes (i.e., increase or decrease) in nine tissue biochemical 
constituents related to collagen type I, β-NADH, FAD, L-tryphophan, elastin, 
hematoporphyrin, 4-pyridoxic acid, pyridoxal 5’-phosphate and water among 
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different types of colonic tissues. The above results demonstrate that AF 
spectroscopy is able to directly assess the biochemical changes of colonic tissue 
associated with cancer transformation in real-time. 
 
Fig. 5.4 Histograms displaying the average compositions of the tissues diagnosed as 
normal, hyperplastic polyp, adenomatous polyp, and cancer. The one standard error 
(SE) confidence intervals as shown for each model component. All nine 
biochemicals are for discriminating four different type of colonic tissues (p<0.05); 
the relative concentration of 4-pyridoxic acid times 0.5 and FAD times 10. 
 
The modeling showed that collagen and elastin AF signals, which represent 
the structural proteins in the extracellular matrix of the colonic wall, are significantly 
lower for precancer and cancer tissue compared to the normal tissue. This could be 
attributed to thickening mucosa layer or replacement of the submucosa by cancerous 
cells and a decrease in the fluorescence emission of submucosa collagen and elastin 
will ensue [159]. These findings are in agreement with collagenases studies which 
usually associate degrading the collagen cross links and decrease in collagen 
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fluorescence during significant tissue architectural changes [171]. Additionally, 
significant reduction in the β-NADH and FAD autofluorescence signal of precancer 
and cancer colonic tissue were also observed. This phenomenon strongly reflects 
changes in the metabolic rate in cancer changes since the nicotinamide adenine 
dinucleotide and flavins play an integral role in cellular metabolism. The ratio of the 
fluorescence of FAD to the sum of the fluorescences of FAD and NADH, which is 
described ‘redox ratio’, typically decreases in cancer, is sensitive to changes in the 
metabolic rate and vascular oxygen supply [179]. On the other hand, AF signals 
from hematoporphyrin which is an endogenous porphyrin formed by the acid 
hydrolysis of hemoglobin has been found to be higher for the precancer and cancer 
colonic tissue than normal tissue. The accumulation of hematoporphyrin in various 
types of cancer was discovered and exploited since 1950s [153] and it has been 
established for photodetection or photodynamic therapy of colon cancer since 
hematophophyrin fluorescence was higher in cancer than in surrounding mucosa in 
specimens [172]. Significant reduction in the L-tryptophan AF signal of precancer 
and cancerous colonic tissue was also observed, suggesting that a mechanism by 
which cancer-related immune stimulation affected the tryptophan depletion [180]. 
On the top of these, vitamin B6, whose main circulation form is pyridoxal 5’-
phosphate (PLP) and major excretion product is 4-pyridoxic acid, is important in 
one-carbon metabolism, which is critical for DNA synthesis and DNA methylation, 
both of which are potential involved in colorectal carcinogenesis [181]. Our 
observations that lower pyridoxal 5’-phosphate and higher 4-pyridoxic acid in 
precancer and cancerous colonic is agreement with vitamin B6 deficiency study 
which usually associate risk for colon cancer and colon adenoma [160, 168, 182].  
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To investigate potential of fitting coefficients for generating diagnostic 
algorithms for effective classification of colonic normal, hyperplastic polyp, 
precancer (adenomatous polyp), and cancer, we employ linear discriminant analysis 
(LDA). LDA determines the discriminant function that maximizes the variances in 
the data between the groups while minimizing the variances between members of 
the same group. All nine significant biochemicals were loaded into a LDA model. 
Table 5.1 summarized the diagnostic indices for classifying the four different types 
of colonic tissues (normal, hyperplastic poly, adenomatous polyp, and cancer). 
Cancer can be 100% correctly classified from normal, hyperplastic polyp and 
adenomatous polyp. 88.8% of normal colonic tissue was identified based on the 
relative concentration of nine biochemicals, but 12 normal spectra were 
misclassified as hyperplastic polyp and 1 normal spectrum was  misclassified as 
adenomatous polyps. For the adenomatous polyps, 73.4% spectra were correctly 
identified. However, the diagnostic sensitivity for the hyperplastic polyp was only 
47.9%, 24 of 48 spectra were classified as normal. This result is not surprising. 
Since the hyperplastic polyps are noncancerous and treated as benign in clinic. 
Therefore, the biochemicals are not sufficient to distinguish the changes of 
endogenous fluorophores between normal and hyperplastic polyp in the colon. The 
biochemicals based diagnostic algorithm yielded overall accuracies of 84.4%, 84%, 
95.8%, and 100% respectively, for classification of colonic normal, hyperplastic 
polyp, adenomatous polyps, and cancer tissues based on the concentration of nine 




Table 5.1 Classification results of nine biochemicals for the four colonic tissue 
groups using LDA algorithms. 
Tissue type Biochemical prediction 
 Normal Hyperplastic polyp Adenomatous polyp Cancer Total
Normal 103 12 1 0 116 
Hyperplastic 
polyp 
24 23 1 0 48 
Adenomatous 
polyp 
4 5 25 0 34 
Cancer 0 0 0 65 65 
Sensitivity 88.8% 47.9% 73.4% 100%  
Specificity 81% 92.1% 99.1% 100%  
Accuracy 84.4% 84% 95.8% 100%  
 
5.3.2 Ex vivo colonic paired specimens 
Based on the successful application of biochemical model fitting on the in vivo 
colonic tissues, we further explore the biochemicals analysis on the resected colonic 
paired tissues (normal vs. cancer). We run the same NNCSLM modeling to estimate 
the concentration of nine reference biochemicals for the ex vivo colonic tissues and 
employ LDA algorithm to classify the cancer from normal colonic tissue. We 
compare the trends in biochemical changes between in vivo and ex vivo colonic 
tissues.  
Fig. 5.5 is the mean AF spectra ±1 standard error (SE) of normal (n=68) and 
cancer (n=32) colonic tissues. We acquired spectra from paired tissue after surgical 
resections without any chemical processing and frozen. The cancer tissue shows the 
significant lower intensity compared to normal ones. We cannot directly compare the 
intensity for these two different datasets (i.e., in vivo vs. ex vivo) since the spectra 
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are not acquired from the same patients. But we find that the SE for the resected 
colonic tissues have larger variations for normal and cancer tissues than those of in 
vivo tissues, although ex vivo colonic tissues has smaller data size (100 spectra) than 
in vivo ones (263 spectra). This is because the molecular spectroscopic properties are 
highly dependent on environmental effects. After being resected from living 
environment, ex vivo specimens did undergo some changes and thus, the 
concentration and distribution of endogenous fluorophores are different from in vivo 
condition consequently. In this section, we employ the biochemical modeling to 
estimate the concentration of endogenous fluorophores for the ex vivo colonic 
tissues and compare the difference between in vivo and ex vivo colonic specimens. 




















Fig. 5.5 Ex vivo mean NIR AF spectra ±1 standard error (SE) of normal (n=68) and 
cancer (n=32) colonic tissue. The shaded areas in tissue AF spectra stand for the 
respective standard error.  
 
The same nine references biochemicals as shown in Fig. 5.2 (i.e., collagen 
type I, β-NADH, FAD, L-tryptophan, Elastin, hematoporphyrin, 4-pyridoxic acid, 
pyridoxal 5’-phosphate and water) were used to fit the measured spectra from 
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resected colonic tissues by using NNCSLM model individually and the relative 
concentration for nine reference biochemicals can be obtained. Fig. 5.6 shows the 
representative fitting results for normal and cancer tissue, respectively. Small fit-
residuals (of <5%) between the reconstructed AF spectra and the measured AF 
spectra can be achieved.  
 
Fig. 5.6 Comparison of ex vivo colonic AF spectra measured with the 
reconstructed tissue AF spectra through the employment of the nine basis reference 
AF spectra: (a) normal and (b) cancer colonic tissues. Residuals (measured 
spectrum minus reconstructed spectrum) are also shown in each plot. 
 
Fig. 5.7 shows the mean fit coefficients for each of the reference 
biochemicals in ex vivo normal and cancer tissue. Student’s t-test illustrates that 
cancer colonic tissues are associated with lower fit coefficient belonging to collagen 
(p=5.31E-3), β-NADH (p=5.28E-6), FAD (p=3.34E-5), L-tryptophan (p=2.89E-2), 
elastin (p=2.82E-5), pyridoxal 5’-phosphate (p=3.87E-4), and water (p=0.33) while 
higher fit coefficients belonging to hematoporphyrin (p=3.84E-3), 4-pyridoxic acid 
(p=7.46E-3), as compared to normal tissues. Compared with the fitting results for in 
vivo colonic tissue, the relative concentration for each biochemical changed 
accordingly. For instance, the decreased concentrations of β-NADH, FAD, L-
tryptophan are probability due to the changed metabolic activities that are affected 
by resection. However, the trend in biochemical changes between normal and cancer 
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colonic tissue are the same for ex vivo and in vivo colonic tissues, except water. For 
the ex vivo condition, normal tissues have the higher water concentration than 
cancer colonic tissue. The trend in the change of water concentration is reverse for in 
vivo condition. This might be attributed to the artifacts induced by storage and 
measurements of ex vivo colonic tissues. For example, the specimens are stored in 
the saline solution after resection and measured with water in order to keep the 
moisture. 
 
Fig. 5.7 Histograms displaying the average compositions of the tissues diagnosed 
as normal and cancer. The one standard error (SE) confidence intervals as shown 
for each model component. All biochemicals are significant for discriminating 
two different type of colonic tissues (p<0.05). 
 
Nine significant biochemicals are loaded into the LDA model to develop 
effective diagnostic algorithms for diagnosis of colon cancer. Fig. 5.8 shows the 
classification results of NIR AF spectra of ex vivo paired normal and cancer colonic 
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tissue using LDA together with the leave-one spectra-out, cross validation 
techniques. Based on the relative concentration of biochemicals, the LDA algorithm 
provides a diagnostic sensitivity 84.3% (27/32) and specificity of 88.2% (60/68) for 
distinguish cancer from normal colonic tissue. We further evaluate the performance 
of the LDA diagnostic algorithm derived from nine significant biochemicals for ex 
vivo colonic NIR AF datasets.  Fig. 5.9 shows the receiver operation characteristic 
(ROC) curve that is generated from the scatter plot in Fig. 5.8 at different threshold 
levels. The ROC curve displays the discrimination results using LDA diagnostic 
algorithms together with the leave-one spectrum-out, cross validation method. The 
integration area under the ROC curve is 0.945.  
 
Fig. 5.8 Scatter plot of the posterior probabilities belongs to normal and cancer 
colonic tissue using the LDA algorithms. The separate line yields a diagnostic 
sensitivity of 84.3% (27/32) and 88.2% (60/68) for distinguishing cancer from 
normal colon tissues. 
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Fig. 5.9 Receiver operating characteristic (ROC) curve of discrimination results 
of normal and cancer colonic tissue using the LDA algorithm based on relative 
concentration for nine biochemicals. The integration areas under the ROC curves 
are 94.5. 
 
5.4  Conclusion 
Based on the high quality NIR AF spectra acquired from different types of colonic 
tissues, The NNCSLM fitting model was implemented to estimate the relative 
concentration of biochemicals for ex vivo normal and cancerous colonic tissue, and 
in vivo normal, hyperplastic polyp, adenomatous polyp, and cancerous colonic tissue. 
The AF spectral biochemical analysis shows significant differences among different 
types of colonic tissues and provides new insights into biochemical origins of NIR 
AF for diagnosis and characterization of colonic precancer and cancer. In this 
chapter, we investigate for first time (to our knowledge) the potential endogenous 
fluorophores responsible for the colonic NIR AF spectrum and explore the changes 
of endogenous fluorophores associated with cancer transformation. We further 
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employ LDA diagnostic algorithms to distinguish precancer (adenomatous polyp) 
and cancer from normal tissue. The good classification results demonstrate the 
potential of NIR AF spectroscopy to be a technique to be a clinical complement to 
conventional WLR endoscopy for improving in vivo detection and diagnosis of 
colonic precancer and cancer at molecular level. 
One noted that the NNCLSM modeling of NIR AF spectra only served as a 
semi-quantitative estimation of biochemical compositions of colonic tissue and the 
results obtained should be interpreted with caution. This is because: (i) the 
NNCLSM modeling only includes the most essential endogenous fluorophores that 
are known to be associated with the structural matrix of tissues or involved in 
cellular metabolic processes; (ii) the in vitro biochemical conformations may not 
truly reflect the in vivo conditions; (iii) the spectral reconstruction does not take into 
account for the effects of tissue optical properties (e.g., tissue absorption and 
scattering), the nonuniform fluorophore distribution in tissue and, in particular, the 
depth-associated variations of NIR AF signals. To better understand the relationships 
between the tissue morphologic/biochemical changes and the tissue NIR AF spectra 
for further improving tissue diagnosis and classification, confocal NIR AF 
microspectroscopy should be explored on the colonic tissue in vivo and in vitro, by 
measuring the complete NIR AF spectra of specific tissue microstructures, or 
alternatively by mapping the distributions of some specific NIR AF peaks or 
principal components within a tissue, or even mapping the biochemical distributions 
at different tissue depths for association with neoplastic transformation in colonic 
tissue. In addition, how the absorbers (e.g., hemoglobin) in tissue attenuate the NIR 
excitation light, and thus attenuating tissue NIR AF emission and modulating NIR 
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AF spectral shape should be studied further. Thus, a more complete NNCLSM 
biochemical modeling integrated with tissue optical properties (e.g., absorption and 
scattering coefficients, anisotropy, tissue thickness, etc.), and light propagation in 
multilayer tissue model with Monte Carlo simulation warrants further investigation. 
Nevertheless, within these limits, we have shown that in vivo estimation of colonic 
intrinsic biochemicals compositions can be largely realized with highly 
representative biochemicals responsible for tissue NIR AF emission, and the fitting 
results correlate well with hispathological findings. Therefore, the distinctive 
differences in NIR AF spectra among benign, precancer, and cancer colonic tissues 
confirm the potential role of endoscopic image-guided NIR AF spectroscopy for 
improving in vivo diagnosis of colonic precancer and cancer during clinical 
colonoscopic screenings. 
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Chapter 6 Integrated Visible and Near-infrared 
Diffuse Reflectance Spectroscopy for Improving 
Colonic Cancer Diagnosis  
6.1  Introduction of Diffuse Reflectance Spectroscopy 
In recent years, a range of spectroscopies have been investigated for distinguishing 
malignant tissue in real time to minimize the artifacts by sampling errors, such as 
elastic-scattering [183-184], fluorescence [115, 154, 185], and Raman 
spectroscopies [114, 126, 146, 151]. Diffuse reflectance (DR) spectroscopy is one of 
the simplest elastic-scattering spectroscopic techniques for studying biological tissue 
and it is the technique that measures the diffuse reflection from the tissue surface to 
determine absorption and scattering properties of sampled tissues [186]. DR 
spectroscopy, which is able to noninvasively and quantitatively determine the optical 
absorption and scattering properties of a turbid medium, can provide pathologically 
relevant information about living tissues, including tissue morphology, as well as the 
size, shape and, density of cells [187]. The changes of tissue optical property 
associated with the malignant transformation directly affect tissues diffuse 
reflectance. For instance, during the progression from normal to neoplastic, an 
increase in blood absorption below 600 nm, which is due to the development of neo-
vascularization inherent to tumor tissue, would be the most obvious change within a 
diffuse reflectance spectrum. Hence, DR spectroscopy can help to track architectural 
and morphological changes associated with malignant transformation in tissue [188].  
Currently, DR spectroscopy has been widely exploited in several applications 
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related to diagnosis, prognosis, and assessing treatment response of cancers in 
different organs [189-195]. These studies only focused on the visible (VIS) range. In 
VIS range, the absorption coefficient of tissue is assumed to be a linear combination 
of absorbers specific to the tissue type sampled such as hemoglobin in blood, beta-
carotene, and melanin [196]. However, a pronounced water absorption peak, which 
appears in the near-infrared (NIR) range around 970 nm [197], has been disregarded 
in these VIS DR studies. Water, which is one of the main components in the tissue 
and cells, has also been used to probe cancers [198]. By measuring the broadband 
DR, additional information regarding the disposition of tissue water can be obtained 
to improve the detection and classification accuracy of the suspected lesions [199].  
In this study, we extend the previous VIS DR work to a wide range of 
wavelength including the NIR domain (with the spectral ranges of 400-1000 nm). A 
rapid-acquisition DR spectroscopy system developed in house was used to acquire 
both VIS and NIR DR spectra at the same time from colonic normal and cancer 
tissue. Principal component analysis (PCA) and linear discriminant analysis (LDA) 
were then used to test and compare the performance of integrated VIS and NIR 
(VIS-NIR), VIS, and NIR DR spectroscopy for colonic tissue classification.  
 
6.2  Diffuse Reflectance Spectroscopy System 
The system comprised a tungsten halogen light source (HL-2000, Ocean Optics Inc., 
Dunedin, FL), a bifurcated fiber (R400-7-VIS/NIR, Ocean Optics Inc., Dunedin, FL) 
for delivery and collection, and spectrometers (QE65000-FL, FWHM=6nm, Ocean 
Optics, Dunedin, FL). The white light source is coupled into a bifurcated fiber to 
illuminate the tissue directly. The fiber probe (2 m in length; 6.33 mm in outer 
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diameter), consists of 6 delivery fibers (core diameter of 400 μm) surrounding the 
central light collection fiber (core diameter of 400 μm, NA=0.22). Tissue diffuse 
reflectance signals collected by the bifurcated fiber and were fed into a scientific-
grade spectrometer. The tissue DR spectra were displayed on the computer screen in 
real time and could be saved for further analysis. The system acquired spectra over 
the wavelength range of 400-1000 nm and each tissue DR spectra were acquired in 8 
ms.  
6.3  Results and Discussion 
106 integrated VIS-NIR DR spectra of colonic tissue were acquired from 7 paired 
colonic tissues, in which 48 were from cancer tissues and 58 were from normal 
tissues. Fig. 6.1 shows the mean DR spectra ±1 standard error (SE) of normal (n=58) 
and cancer (n=48) colonic tissues in the colon.  The paired Student’s t-test on the 
mean differences of spectral intensities point by point in the ranges 400-1000 nm 
between normal and cancer tissue revealed that the integrated VIS-NIR DR intensity 
differences between normal and cancer tissues were significant with a p<0.05. The 
ratios of DR spectra of normal and cancer tissues are not flat horizontal lines but 
decrease from 400 to 500 nm and then have two obvious peaks near 540 nm, 580 nm 
and finally increase till 1000 nm (data not shown). The spectral shape differences 
from 400 to 1000 nm are apparent for DR spectra between colonic normal and 
cancer tissues. Three pronounced valleys near 420 nm, 540 nm, and 580 nm, which 
are attributed to strong oxy- and deoxy-hemoglobin absorption [196], can be clearly 
identified for both normal and cancer colonic tissues. The two hemoglobin 
absorption valleys around 540 nm and 580 are larger and more obvious on the 
cancer tissue spectral curve than on the normal one. The colonic normal tissues 
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possessed absorption peaks around 420 nm which were slightly red-shifted 
compared to the corresponding peak within the mean cancer spectra. In the NIR 
range, we also observe variations between normal and cancer tissues. The water 
absorption valley around 970 nm [200] is more obvious on the cancer spectral curve than 
on the normal one. All of these line-shape differences were therefore explored in 
greater details for tissue classification through principal components analysis (PCA) 
and linear discriminant analysis (LDA).  


















 Cancer (n=48) 
 Normal (n=58)
 
Fig. 6.1 The mean integrated visible and near-infrared (VIS-NIR) diffuse reflectance 
(DR) spectra ±1 standard error (SE) of normal (n=58) and cancer (n=48) colonic 
tissue. The shaded areas in tissue DR spectra stand for the respective standard error.  
 
The differences of DR spectra between colonic normal and cancer tissue 
could be attributed to the changes of tissue optical properties in the colon [84], for 
example the higher absorption may reflect the increase in the percentage of 
hemoglobin and water in colonic cancer tissues associated with dysplastic 
transformation. The colonic tissue DR spectra are dominate by the characteristic 
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hemoglobin and water absorption bands, near 420 nm, 540 nm, 580 nm and 1000 
nm. There are distinctive DR spectral differences between normal and cancer tissues 
in the whole spectral region (400-1000 nm). To understand and interpret these 
spectral differences between normal and cancer tissues, it is important to know 
where the spectral signals come from within the tissue. In the VIS region of the DR 
spectra, Hemoglobin, which is present in vascularized tissues, has two primary 
bands of absorption: Soret (peak=420 nm), and Q-bands (peaks=542 and 577 nm) 
[55]. Hemoglobin is considered the most important absorber for differentiating 
normal from malignant tissues [185]. The intrinsic absorption spectral fingerprint of 
oxyhemoglobin (HbO2) and deoxyhemoglobin (Hb) at the VIS wavelength range 
allows optical methods to quantitative tissue angiogenesis and hypoxia 
noninvasively [201]. Our results showed that colonic cancer tissue has higher 
absorption than normal tissues near 540 nm, 580 nm. These findings are in 
agreement with previous reports that demonstrate an increase in blood absorption 
during colon carcinogenesis from normal to malignant tumors  [201]. The significant 
increase in the blood volume fraction of the malignant lesions could be attributed to 
the increased microvasculature of malignant tumors and accordingly the increased 
blood content and poor oxygenation [202]. The observation of the change of 420 nm 
absorption band position between normal and cancer colonic tissue are consistent 
with reports that normal colonic tissue possessed absorption peaks at 430 nm which 
were red-shifted compared to the adenomatous spectra with a band at 415 nm [195]. 
Moreover, in the NIR region we also observe that colon cancer also has higher water 
absorption in the NIR around 970 nm compared to normal tissues. Water have a 
pronounced absorption peak in the NIR around 970 nm [197], that is due to the 
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combination of the first harmonic of the O-H symmetric stretch vibration and the 
fundamental anti-symmetric stretch vibration from hydrogen bound O-H [200]. The 
characteristics of this peak (970 nm) are sensitive indicator of the local environment 
of water molecules [199]. This phenomenon strongly reflects the changes of the 
metabolic rate in cancer since water provides the conversion of mechanical energy 
developed by contractile proteins into the chemical energy useful in cell process 
[178]. Our observations that higher water absorption in colonic cancer is in 
agreement with our studies of biochemical modeling of colon tissues, which shows 
the increased water content of colon tissue compared to the benign tissues [154]. In 
addition, the changes of tissue microstructure scattering properties (e.g. nucleus size) 
could also contribute to the significant differences of DR spectra between normal 
and colonic cancer tissues [203]. However, it still poorly understood due to the 
complex nature of the tissue scattering process and it warrants further investigation. 
We have also employed the multivariate statistical technique [i.e., PCA and 
LDA] by utilizing the integrated VIS-NIR DR spectra (400-1000 nm) to determine 
the most diagnostically significant DR features for colonic tissue classification. Fig. 
6.2 shows the ten principal components (PCs) loadings calculated from PCA on the 
integrated VIS-NIR DR spectra (400-1000 nm). Some PC features (Fig. 6.2) with 
peaks and troughs at positions similar to those of absorption of hemoglobin and 
water in tissue DR spectra (Fig. 6.1). The first PC accounts for the largest variance 
(93.14%), whereas successive PCs describe features that contribute progressively 
smaller variances. The unpaired, two sided Student’s test on the obtained principal 
components (PCs) shows that only seven PCs (PC3, PC4, PC5, PC7, PC8, PC9, and 
PC10) that were diagnostically significant (p<0.05) for discriminating cancer from 
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normal colonic tissue. Then all these seven significant PCs were loaded into LDA 
model to develop effective diagnostic for colonic tissue diagnosis.  


















Fig. 6.2 The ten principal components (PCs) accounting more than 99% of the total 
variance calculated from the integrated VIS/NIR DR spectra (PC1~93.14%, 
PC2~4.64%, PC3~1.38%, PC4~0.48%, PC5~0.23%, PC6~0.06%, PC7~0.02%, 
PC8~0.014%, PC9~0.01%, PC10~0.01%).  
 
To compare the diagnostic capability of integrated VIS-NIR DR, VIS, and 
NIR DR spectra, we employ the PCA-LDA-based spectral classification with the 
leave-one spectrum-out, cross validation method on these three data set respectively. 
Fig. 6.3 shows the posterior probabilities of belonging to the normal and cancer 
groups as calculated for (a) integrated VIS-NIR (400-1000 nm), (b) VIS (400-700 
nm), and (c) NIR (700-1000 nm) DR spectra. The classification results showed that 
87.5% (42/48), 85.4% (41/48), and 83.3% (40/48) of cancer tissues were correctly 
classified (diagnostic sensitivity) using the three spectral data sets (i.e. integrated 
VIS-NIR, VIS, and NIR DR spectra), respectively. The diagnostic specificities were 
94.8%, 81.03%, and 74.1%, and overall diagnostic accuracies were 91.5%, 83.02%, 
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and 78.3% for the integrated VIS-NIR, VIS, and NIR DR spectra, respectively.  
 
Fig. 6.3 Scatter plot of the posterior probability belonging to the normal and cancer 
colonic tissue calculated from the data sets of (a) integrated VIS/NIR, (b) VIS, and 
(c) NIR, respectively, using the PCA-LDA algorithms, together with the leave-one 
tissue site-out, cross validation method with three different spectral spaces.  
 
To further evaluate and compare the performance of the PCA-LDA based 
diagnostic algorithms derived from three data sets for tissue classification, ROC 
curve (Fig. 6.4) were generated from the scatter plot in Fig. 6.3 at different threshold 
levels, displaying the discrimination results using the integrated VIS-NIR, VIS, and 
NIR DR spectra, respectively. The integration area under the ROC curve is 0.97, 
0.93, and 0.878, for integrated VIS-NIR, VIS, NIR DR spectra, respectively. A 
comparative evaluation of the ROC curves indicates that the either VIS or NIR DR 
spectra alone can be used for tissue diagnosis with high diagnostic sensitivity and 
specificity. Among these three diagnostic algorithms derived from the three spectral 
data sets, the integrated VIS-NIR DR spectra, which contains both hemoglobin and 
water signatures, generated better diagnostic accuracy than the single VIS and NIR 
spectral ranges, as illustrated by the improvement in the sensitivity and specificity 
(Fig. 6.4).  
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Fig. 6.4 Receiver operating characteristic (ROC) curve of discrimination results for 
integrated VIS-NIR, VIS, and NIR DR spectra, respectively, using PCA-LDA 
algorithms, together with the leave-one tissue site-out, cross validation method. The 
integration areas under the ROC curve are 0.973, 0.93, and 0.878, respectively, for 
integrated VIS-NIR, VIS, and NIR DR spectra. 
 
In summary, we have demonstrated that high-quality integrated VIS-NIR DR 
spectra can be acquired from colonic tissue within 8 ms. The results suggest that 
cancer tissue had greater absorption of hemoglobin and water than normal colonic 
tissue. The integrated VIS-NIR DR spectroscopy combined with PCA-LDA 
techniques can be used to capture the diagnostically important spectral features that 
maximize differentiation between colonic normal and cancer tissue. This model 
showed that, although the VIS or NIR spectroscopic technique alone, can be used to 
differentiate cancer tissue from colonic normal tissue with fairly high accuracy, the 
integrated VIS-NIR DR spectra, which contained both hemoglobin and water 
signatures, can further improve the diagnostic accuracy (Fig. 6.4). Despite the small 
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case number, the performances of the diagnostic algorithms derived from integrated 
visible and NIR in an unbiased manner with the leave-one-out, cross-validation 
method are very promising for improving colon cancer diagnosis (Fig. 6.3). 
Therefore, with the development of minimized size of fiber probe that can be 
coupled into the biopsy channel of commercial colonoscopy, we can combine the 
integrated VIS-NIR DR spectroscopy and AF spectroscopy for in vivo diagnosis of 
colon cancer during endoscopic examination.  
To our knowledge, the use of the integrated VIS-NIR DR spectra together 
with the multivariate statistical techniques reported here is the first demonstration of 
principal this optical technique have potential to be applied to noninvasive in vivo 
tissue diagnosis. Best differentiation between normal and cancer colonic tissues can 
be achieved using the integrated VIS-NIR DR spectroscopy (400-1000 nm) as 
compared to VIS or NIR DR spectroscopy. Therefore, we conclude that the 
integrated VIS-NIR spectroscopy is a promising technique that may yield an 
effective and clinically useful diagnostic schema for improving early diagnosis of 




Chapter 7 Conclusions and Future Directions 
7.1  Conclusions 
The motivation for research in this dissertation stemmed from the refinement of 
conventional colonoscopy for improving the detection of colon cancer. After a 
comparison of different advanced techniques used to complement the colonoscopy, 
AF technique shows a promising potential to provide the real-time information of 
endogenous fluorophores that are associated with morphological structure and 
metabolic processes. Most of AF studies, which used the UV or VIS wavelength for 
excitation, are not capable to detect lesions in deeper areas with the limited 
penetration depth. We, therefore, extended our AF work to the NIR domain and 
demonstrated the feasibility of using NIR AF/DR imaging and spectroscopy 
techniques for the early detection of precancer and cancer in the colon.  
We have developed an integrated NIR AF and DR imaging system combined 
with polarization technique to detect the NIR AF emission under different 
polarization conditions of colonic tissues. A total of 48 paired colonic tissue 
specimens (normal vs. cancer) were measured using the integrated NIR DR (850-
1100 nm) and NIR AF imaging at the 785 nm laser excitation. The results showed 
that NIR AF intensities of cancer tissues are significantly lower than those of normal 
tissues (p<0.001, paired 2-sided Student’s t-test, n=48). In addition, NIR AF imaging 
under polarization conditions gives a higher diagnostic accuracy (of ~92-94%) 
compared to non-polarized NIR AF imaging or NIR DR imaging. Moreover, the 
ratio imaging of NIR DR to NIR AF with polarization provides the best diagnostic 
accuracy (of ~96%) among the NIR AF and NIR DR imaging techniques. This work 
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suggests that the integrated NIR AF/DR imaging under polarization condition has 
the potential to improve the early diagnosis and detection of malignant lesions in the 
colon.  
Then, we integrated a novel flexible fiber probe into our NIR AF 
spectroscopy system to realize in vivo measurement of NIR AF spectra from 
different types of colonic tissues during the endoscopic examination. A total of 198 
in vivo composite NIR AF and Raman spectra were acquired from normal (n=116), 
hyperplastic (n=48), and adenomatous polyp (n=34)) colonic tissues at 785 nm laser 
excitation under white-light reflectance (WLR) endoscopic guidance. Significant 
differences (p<0.05, ANOVA) in in vivo NIR AF spectra associated with Raman 
peaks are observed among colonic normal, hyperplastic, adenomatous polyps, and 
cancer tissues in the spectral ranges of 810-1050 nm. Multivariate statistical 
techniques, including PCA and LDA together with the leave-one tissue site-out, 
cross validation, were used to develop diagnostic algorithms for classification of 
subtypes of colonic polyp based on spectral characteristics. The diagnostic 
algorithms yield sensitivities of 83.6%, 77.1%, and 88.2%, and specificities of 
96.3%, 88%, and 92.1% respectively, for classification of colonic normal, 
hyperplastic, and adenomatous polyps. Good classification among different types of 
colonic tissue can be achieved using PCA-LDA diagnostic algorithms, indicating the 
potential of NIR AF to be a clinically complement to conventional WLR endoscopy 
for the rapid, non-invasive, in vivo identification of precancer (adenomatous polyp) 
during clinical colonoscopic examination. 
To further investigate the origins of tissue biochemicals responsible for the 
NIR AF differences among different types of colonic tissues, we have constructed a 
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non-negativity-constrained least squares minimization (NNCLSM) biochemical 
model to estimate the biochemical compositions of colonic tissues. The NIR AF 
spectra from the nine representative biochemicals (i.e., collagen I, elastin, β-NADH, 
FAD, L-tryptophan, hematoporphyrin, 4-pyridoxic acid, pyridoxal 5’-phosphate, and 
water) in colonic tissue were found to the most significant for optimal fitting the 
measured in vivo NIR AF spectra colonic tissue. Colonic precancer and cancer 
tissues show lower fit coefficients belonging to collagen I, FAD, β-NADH, L-
tryptophan, and pyridoxal 5’-phosphate, and higher fit coefficients belonging to 
hematoporphyrin, 4-pyridoxic acid, and water as compared to benign tissues. We 
also compare the fitting results for the ex vivo and in vivo colonic specimens. Hence, 
NIR AF spectroscopy provides new insights into biochemical changes of colonic 
tissue associated with cell proliferation and metabolic rate during the cancer 
progression.   
We also evaluate the diagnostic ability of the integrated VIS-NIR DR 
spectroscopy technique for detection and diagnosis of colonic cancer. High-quality 
DR spectra with the spectral ranges of 400-1000 nm from normal and cancer colonic 
mucosal tissue were acquired. And significant differences are observed in DR 
spectra between normal (n=58) and cancer (n=48) colonic tissue, particularly in the 
spectral bands near 420, 540, 580 and 1000 nm, which are primarily correlated to 
absorption of hemoglobin and water. By using PCA-LDA algorithm, classification 
results of three spectral data sets (i.e. integrated VIS-NIR, VIS, and NIR DR spectra) 
showed diagnostic sensitivities of 87.5%, 85.4%, and 83.3%; specificities of 94.8%,  
81.03%, and 74.1%; and overall diagnostic accuracy of 91.5%, 83.02%, and 78.3% 
respectively, for colonic cancer identification. This study suggests that the integrated 
 114
VIS-NIR DR spectroscopy associated with PCA-LDA diagnostic algorithms has the 
potential for improving the early diagnosis and detection of colonic cancer.  
7.2  Future Directions 
While the works in the thesis contributed to the advancement of NIR AF/DR 
imaging and spectroscopy for the detection of colon cancer, they do suffer from 
some limitations, and thus, provide the directions for future studies.  
i). Integration of NIR AF/DR imaging and spectroscopy system  
Our NIR AF imaging system is limited for the ex vivo measurements due to its 
experimental setup. With further miniaturization of the current NIR excitation and 
detection devices, we plan to couple the NIR AF imaging system into conventional 
endoscopes and realize in vivo measurement during colonoscopic screening in the 
future. Moreover, with the development of the endoscope-based fiber probe, we can 
also integrate the NIR AF and DR spectroscopy to the commercial endoscopy 
system. As a complement to conventional white-light endoscopy, NIR AF/DR 
imaging and spectroscopy system can provide wealth of morphological and 
biochemical information for improving in vivo detection and diagnosis of precancer 
and cancer in the colon and it can further assist doctor to minimize incision and 
dissection inaccuracies, and permit real-time confirmation of complete resection.  
ii). On-line classification of different types of colonic tissues 
In this thesis, we only run all the multivariate statistical analysis off-line. In the 
clinical, the real-time biopsy is critical for effectively removing the lesions with 
cancerous potential during colonoscopic screening. Therefore, we aim to develop an 
algorithm that can classify the subtype so colonic polyps on-line. This real-time 
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classification function would assist endoscopists for accurate biopsy, and 
consequently reduce the risk and cost for polypectomy. However, in this thesis, we 
have only evaluated the classification of hyperplastic and adenomatous colonic 
polyp. In pathology, adenomatous polyps can be further divided into tubal, villous, 
and tubulo-villous different types. Thus, to realize real-time classifying of different 
types of colonic polyps during colonoscopic examination, the multivariate statistical 
algorithm needs more complicated training. 
iii). Multi-layer colonic tissue model for chemical analysis 
Currently, our biochemical modeling only served as a semi-quantitative estimation 
of biochemical compositions of colonic tissue. The NNCLSM modeling only 
includes the most essential endogenous fluorophores which are known to be 
associated with the structural matrix of tissues or involved in cellular metabolic 
processes. Thus, this in vitro biochemical conformation may not truly reflect the in 
vivo conditions. Moreover, the spectral reconstruction does not take into account for 
the effects of tissue optical properties, such as absorption and scattering. To better 
understand the relationships between the tissue morphologic/biochemical changes 
and the tissue NIR AF spectra for further improving tissue diagnosis and 
classification, confocal NIR AF microspectroscopy should be explored on the 
colonic tissue in vivo and in vitro, by measuring the complete NIR AF spectra of 
specific tissue microstructures, or alternatively by mapping the distributions of some 
specific NIR AF peaks or principal components within a tissue, or even mapping the 
biochemical distributions at different tissue depths for association with neoplastic 
transformation in colonic tissue. Thus, a more complete NNCLSM biochemical 
modeling integrated with tissue optical properties (e.g., absorption and scattering 
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coefficients, anisotropy, tissue thickness, etc.), and light propagation in multilayer 
tissue model with Monte Carlo simulation warrants further investigation. 
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A.1 American Joint committee on Cancer Staging of Colon Cancer [14] 
The tumor-node-metastasis (TNM) systems of the American Joint Committee on 
Cancer (AJCC), the four stages are based on the depth of invasion of the primary 
tumor (T), lymph node status (N), and distant metastasis (M). Approximately 39% 
of colon and rectum cancer cases are diagnosed while the cancer is still confined to 
the primary site (localized stage or stage I/IIa), 36% are diagnosed after the cancer 
has spread to regional lymph nodes (stage III) or directly beyond the primary site 
(stage IIb) and 19% are diagnosed after the cancer metastasized (distant stage or 
stage IV). 
Stage T N M 
Stage I T1-2 N0 M0 
Stage IIA T3 N0 M0 
Stage IIB T4a N0 M0 
Stage IIC T4b N0 M0 
























Stage IVA Any T Any N M1a 
Stage IVB Any T Any N M1b 
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Wavelength of max. 
Fluorescence excitation (nm) 
Wavelength of max. 
Fluorescence emission (nm) 
Tryptophan Amino acids 280 350 
Phenylalanine  260 280 
Tyrosine  275 330 
Collagen Connective tissue 330-340 400-410 
Elastin Extracellular matrix 350,420 420,510 
NADH Metabolic cofactors 340 450 
FAD, flavins  450 515 
Pyridoxine Vitamin B6 compunds 330,340 400 
Pyridonxal-5’-phosphate  330 400 
Porphyrins By-product of heme biosynthesis; 
bacterial fauna 
400-450 635,690 
Ceroid, lipofuscin Lipopigment granules;  
age related;  
lipid oxidation products 
340-395 430-460,540-640 
 
